{"text_format":"1","workbook":"xlsx","n_sheets":54,"sheets":["Contents","Attestation","ESG risks","Template EU CR3","EU CRC","EU OV1","EU KM1","EU OVC","Table EU OVA","Table EU OVB","Template EU LI1","Template EU LI2","Template EU LI3","Table EU CCA","Table EU LIA","EU PV1","EU CC1","EU CC2","EU CCYb1","EU CCYb2","EU LR1","EU LR2","EU LR3","Table EU LRA","Table EU LIQA","EU LIQ1","EU LIQB","EU LIQ2","Table EU CRA","Table EU CRB","EU CR1-A","Table EU CRD","EU CR4","EU CR5","Table EU CCRA","EU MRA","EU CCR1","EU CCR2","EU CCR3","EU CRR5","EU CRR8","Table EU ORA","Template EU OR1","REMA","REM1","REM3","REM4","REM5","Template EU AE1","Template EU AE2","Template EU AE3","Table EU AE4","Table EU IRRBBA","EU IRRBB1"],"not_rendered":{"charts":0,"images":2,"macros":1,"external_links":0,"defined_names":2,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900"}

{"sheet":"Contents","index":0,"n_rows":122,"n_cols":6,"rows_kept":122,"cut":false,"hidden":false,"merged":[]}
[]
[]
[]
[]
[]
[]
[]
[]
[]
[null,null,null,null,null,"Last updated"]
[]
[null,null,null,"Attestation","KBN's disclosure policies and attestation of KBN's Pillar 3 report","Q4 2022"]
[null,null,null,"ESG- risks","Disclosure of environmental, social and governance risks","Q4 2022"]
[]
[null,"Annex I",null,"Template EU OV1","Overview of total risk exposure amounts","Q1 2023"]
[null,null,null,"Template EU KM1","Key metrics template","Q1 2023"]
[null,null,null,"Template EU INS1","Insurance participations"," [Not applicable] "]
[null,null,null,"Templates EU INS2","Financial conlomerates information on own funds and capital adequacy ratio"," [Not applicable] "]
[null,null,null,"Table OVC","ICAAP information"]
[]
[null,"Annex III",null,"Table EU OVA","Institution risk management approach","Q4 2022"]
[null,null,null,"Table EU OVB","Disclosure on governance arrangements","Q4 2022"]
[]
[null,"Annex V",null,"Template EU LI1","Differences between the accounting scope and the scope of prudential consolidation and mapping of financial statement categories with regulatory risk categories","Q4 2022"]
[null,null,null,"Template EU LI2","Main sources of differences between regulatory exposure","Q4 2022"]
[null,null,null,"Template EU LI3","Outline of the differences in the scopes of consolidation (entity by entity)"," [Not applicable] "]
[null,null,null,"Table EU LIA","Explanations of differences between accounting and regulatory exposure amonts","Q4 2022"]
[null,null,null,"Table EU LIB","Other qualitative information on the scope of application"," [Not applicable] "]
[null,null,null,"Template EU PV1","Prudent valuation adjustment","Q4 2022"]
[]
[null,"Annex VII",null,"Template EU CC1","Composition of regulatory own funds","Q4 2022"]
[null,null,null,"Template EU CC2","Reconciliation of regulatory own funds to balance sheet in the audited financial statements","Q4 2022"]
[null,null,null,"Template EU CCA","Main features of regulatory own funds instruments and eligible liabilities instruments","Q4 2022"]
[]
[null,"Annex IX",null,"EU CCYb1","Geographical distribution of credit exposures relevant for the calculation of the countercyclical buffer","Q4 2022"]
[null,null,null,"EU CCyB2","Amount of institution-specific countercyclical capital buffer","Q4 2022"]
[]
[null,"Annex XI",null,"Template EU LR1 - LRSum","Summary reconciliation of accounting assets and leverage ratio exposures","Q4 2022"]
[null,null,null,"Template EU LR2 - LRCom","Leverage ratio common disclosure","Q4 2022"]
[null,null,null,"Template EU LR3 - LRSpl","Split-up of on balance sheet exposures (excluding derivatives, SFTs and exempted exposures)","Q4 2022"]
[null,null,null,"Template EU LRA","Disclosure of LR qualitative information","Q4 2022"]
[]
[null,"Annex XIII",null,"Table EU LIQA","Liquidity risk management","Q4 2022"]
[null,null,null,"Template EU LIQ1","Quantitative information of LCR","Q1 2023"]
[null,null,null,"Table EU LIQB","Qualitative information on LCR","Q1 2023"]
[null,null,null,"Template EU LIQ2","Net Stable Funding Ratio","Q4 2022"]
[]
[null,"Annex XV",null,"Table EU CRA","General qualitative information about credit risk","Q4 2022"]
[null,null,null,"Table EU CRB","Additional disclosure related to the credit quality of assets","Q4 2022"]
[null,null,null,"EU CR1-A","Maturity of exposures","Q4 2022"]
[null,null,null,"Template EU CQ3","Credit quality of performing and non-performing exposures by past due days"," [Not applicable] "]
[null,null,null,"Template ER CR1","Performing and non-performing exposures and related provisions"," [Not applicable] "]
[null,null,null,"Template EU CR2","Changes in the stock of non-performing loans and advances"," [Not applicable] "]
[null,null,null,"Template EU CR2a","Changes in the stock of non-performing loans and advances and related net accumulated recoveries"," [Not applicable] "]
[null,null,null,"Template EU CQ1","Credit quality of forborne exposures"," [Not applicable] "]
[null,null,null,"Template EU CQ2","Quality of forbearance"," [Not applicable] "]
[null,null,null,"Template EU CQ4","Quality of non-performing exposures by geography "," [Not applicable] "]
[null,null,null,"Template EU CQ5","Credit quality of loans and advances by industry"," [Not applicable] "]
[null,null,null,"Template EU CQ6","Collateral valuation - loans and advances "," [Not applicable] "]
[null,null,null,"Template EU CQ7","Collateral obtained by taking possession and execution processes "," [Not applicable] "]
[null,null,null,"Template EU CQ8","Collateral obtained by taking possession and execution processes – vintage breakdown"," [Not applicable] "]
[]
[null,"Annex XVII",null,"EU CRC","Qualitative disclosure requirements related to CRM techniques","Q4 2022"]
[null,null,null,"Template EU CR3","CRM techniques overview:  Disclosure of the use of credit risk mitigation techniques"," [Not applicable] "]
[]
[null,"Annex XIX",null,"Table EU CRD","Qualitative disclosure requirements related to standardised model","Q4 2022"]
[null,null,null,"Template EU CR4","Standardised approach – Credit risk exposure and CRM effects","Q4 2022"]
[null,null,null,"Template EU CR5","Standardised approach","Q4 2022"]
[]
[null,"Annex XXI",null,"Table EU CRE","Qualitative disclosure requirements related to IRB approach"," [Not applicable] "]
[null,null,null,"Template EU CR6","IRB approach – Credit risk exposures by exposure class and PD range"," [Not applicable] "]
[null,null,null,"Template EU CR6-A","Scope of the use of IRB and SA approaches"," [Not applicable] "]
[null,null,null,"Template EU CR7","IRB approach – Effect on the RWEAs of credit derivatives used as CRM techniques"," [Not applicable] "]
[null,null,null,"Template EU CR7-A","IRB approach – Disclosure of the extent of the use of CRM techniques"," [Not applicable] "]
[null,null,null,"Template EU CR8","RWEA flow statements of credit risk exposures under the IRB approach "," [Not applicable] "]
[null,null,null,"Template CR9","IRB approach – Back-testing of PD per exposure class (fixed PD scale)"," [Not applicable] "]
[null,null,null,"Template CR9.1","IRB approach – Back-testing of PD per exposure class (only for  PD estimates according to point (f) of Article 180(1) CRR)"," [Not applicable] "]
[]
[null,"Annex XXIII",null,"Template EU CR10","Specialised lending and equity exposures under the simple riskweighted approach"," [Not applicable] "]
[]
[null,"Annex XXV",null,"Table CCRA","Qualitative disclosure to CCR","Q4 2022"]
[null,null,null,"Template EU CCR1","Analysis of CRR exposure by approch","Q4 2022"]
[null,null,null,"Template EU CCR2","Transactions subject to own funds requirements for CVA risk","Q4 2022"]
[null,null,null,"Template EU CCR3","Standardised approach – CCR exposures by regulatory exposure class and risk weights","Q4 2022"]
[null,null,null,"Template EU CCR5","Composition of collateral for CCR exposures","Q4 2022"]
[null,null,null,"Template EU CCR8","Exposures to CCPs","Q4 2022"]
[null,null,null,"Template EU CCR4","IRB approach – CCR exposures by exposure class and PD scale"," [Not applicable] "]
[null,null,null,"Template EU CCR6","Credit derivatives exposures"," [Not applicable] "]
[null,null,null,"Template EU CCR7","RWEA flow statements of CCR exposures under the IMM"," [Not applicable] "]
[]
[null,"Annex XXVII",null,"Table EU-SECA","Qualitative disclosure requirements related to securitisation exposures "," [Not applicable] "]
[null,null,null,"Template EU-SEC1","Securitisation exposures in the non-trading book"," [Not applicable] "]
[null,null,null,"Template EU SEC2","Securitisation exposures in the trading book"," [Not applicable] "]
[null,null,null,"Template EU SEC3","Securitisation exposures in the non-trading book and associated regulatory capital requirements - institution acting as originator or as sponsor"," [Not applicable] "]
[null,null,null,"Template EU SEC4","Securitisation exposures in the non-trading book and associated regulatory capital requirements - institution acting as investor"," [Not applicable] "]
[null,null,null,"Template EU SEC5","Exposures securitised by the institution - Exposures in default and specific credit risk adjustments"," [Not applicable] "]
[]
[null,"Annex XXIX",null,"Table EU MRA","Qualitative disclosure requirements related to market risk"]
[null,null,null,"Template EU MR1","Market risk under the standardised approach"," [Not applicable] "]
[null,null,null,"Table EU MRB","Qualitative disclosure requirements for institutions using the internal Market Risk Models"," [Not applicable] "]
[null,null,null,"Template E2 MR2-A","Market risk under the internal Model Approach (IMA)"," [Not applicable] "]
[null,null,null,"Template EU MR2-B","RWA flow statements of market risk exposures under the IMA"," [Not applicable] "]
[null,null,null,"Template EU MR3","IMA values for trading portfolios"," [Not applicable] "]
[null,null,null,"Template EU MR4","Comparison of VaR estimates with gains/losses"," [Not applicable] "]
[]
[null,"Annex XXXI",null,"Table EU ORA","Qualitative information on operational risk","Q4 2022"]
[null,null,null,"Template EU OR1","Operational risk own funds requirements and risk-weighted exposure amounts","Q4 2022"]
[]
[null,"Annex XXXIII",null,"Template EU REMA","Remuneration policy","Q4 2022"]
[null,null,null,"Template EU REM1","Remuneration awarded for the financial year","Q4 2022"]
[null,null,null,"Template EU REM2","Special payments to staff whose professional activities have a material impact on institutions’ risk profile (identified staff)"," [Not applicable] "]
[null,null,null,"Template EU REM3","Deferred remuneration ","Q4 2022"]
[null,null,null,"Template EU REM4","Remuneration of 1 million EUR or more per year","Q4 2022"]
[null,null,null,"Template EU REM5","Information on remuneration of staff whose professional activities have a material impact on institutions’ risk profile","Q4 2022"]
[]
[null,"Annex XXXV",null,"Template EU AE1","Encumbered and unencumbered assets","Q4 2022"]
[null,null,null,"Template EU AE2","Collateral received and own debt secutites issued","Q4 2022"]
[null,null,null,"Template EU AE3","Scorces of encumbrance","Q4 2022"]
[null,null,null,"Table EU AE4","Accompany narrative information","Q4 2022"]
[]
[null,"IRRBB",null,"Table EU IRRBBA ","Qualitative information on interest rate risks of non-trading book activities ","Q4 2022"]
[null,null,null,"Template EU IRRBB1","Interest rate risks of non-trading book","Q4 2022"]

{"sheet":"Attestation","index":1,"n_rows":0,"n_cols":0,"rows_kept":0,"cut":false,"hidden":false,"merged":[]}

{"sheet":"ESG risks","index":2,"n_rows":0,"n_cols":0,"rows_kept":0,"cut":false,"hidden":false,"merged":[]}

{"sheet":"Template EU CR3","index":3,"n_rows":12,"n_cols":8,"rows_kept":12,"cut":false,"hidden":true,"merged":[[3,4,5,4]]}
[]
[null,"Template EU CR3 –  CRM techniques overview:  Disclosure of the use of credit risk mitigation techniques"]
[]
[null,null,null,"Unsecured carrying amount ","Secured carrying amount"]
[null,null,null,null,null,"Of which secured by collateral ","Of which secured by financial guarantees"]
[null,null,null,null,null,null,null,"Of which secured by credit derivatives"]
[null,null,null,"a","b","c","d","e"]
[null,1,"Loans and advances",null,null,null," "]
[null,2,"Debt securities ",null,null,null,null,"  "]
[null,3,"Total"]
[null,4,"     Of which non-performing exposures",null,null,null,null,"  "]
[null,"EU-5","            Of which defaulted "]

{"sheet":"EU CRC","index":4,"n_rows":10,"n_cols":5,"rows_kept":10,"cut":false,"hidden":false,"merged":[]}
[null,"Table EU CRC – Qualitative disclosure requirements related to CRM techniques"]
[null,"Free format text boxes for disclosure of qualitative information"]
[]
[]
[null,"Legal basis","Row number","Free format"]
[null,"Article 453 (a) CRR","(a)","A description of the core features of the policies and processes for on- and off-balance sheet netting and an indication of the extent to which institutions make use of balance sheet netting;\n","KBN has entered into ISDA agreements with all derivatives counterparties. This implies that all exposures vs the counterparty may be offset in the event of default. The ISDA agreements contain agreements regarding the exchange of collateral in the form of Credit Support Annex (CSA) related to financial derivatives exposures. Cash collateral received and cash collateral pledged is presented in the Statement of financial position as Deposits with credit institutions or Loans from credit institutions with a related payable to or receivable from credit institutions. Cash collateral received is included in KBN's cash management, and is placed either in commercial paper and bonds or in short term money market instruments. KBN has also pledged securities to derivative counterparties as collateral, 156 million at year-end 2022 (996 million as of year-end 2021). These assets are still recognised in the balance sheet as Commercial paper and bonds. Securities amounting to NOK 3,629 million have also been received as collateral in reverse repurchase agreements. This liability item is not recognised in the balance sheet. \n\nKBN only has offsetting rights for exposures in financial derivatives, and for these, legally binding agreements are used both for offsetting and for collateral. Financial derivatives are presented gross in the Statement of Financial Position because the netting agreements do not meet the conditions for offsetting in the Statement of Financial Position, and payments are normally not netted under normal market conditions. The table below shows the carrying amounts of financial derivatives. Since these are presented gross in the Statement of Financial Position, the financial significance of the offsetting right, that is agreed on in the netting agreements with the derivative counterparties as well as held or pledged cash collateral (variation margin), is quantified and highlighted in separate columns. In the event of default of a derivative counterparty it will be possible to enforce the offsetting right as well as make use of the cash security. The value after offsetting and cash security shows the effect of collateral (variation margin) on credit risk for the derivative positions."]
[null,"Article 453 (b) CRR","(b)","The core features of policies and processes for eligible collateral evaluation and management;","Significant risks must be quantified and measured according to recognised methods and/or models, adapted to the risks they are intended to measure. There must be an overview of risk models that defines ownership, roles, requirements for documentation and requirements for and plan for independent validation of risk models. The CEO approves significant risk models and significant changes to them. The board of directors must be informed about significant assumptions for central models and changes to these."]
[null,"Article 453 (c) CRR\n","(c)\n","A description of the main types of collateral taken by the institution to mitigate credit risk;","The collateral received by KBN as variation margin in derivative transactions is cash. KBN receives bonds as collateral in reverse repo transactions. If required under the provisions of EMIR, initial margin in bilateral transactions will be received in the form of bonds."]
[null,"\nArticle 453 (d) CRR","(d)","For guarantees and credit derivatives used as credit protection, the main types of guarantor and credit derivative counterparty and their creditworthiness used for the purposes of reducing capital requirements, excluding those used as part of synthetic securitisation structures;","KBN also grants loans to companies that perform tasks for municipalities and counties. The prerequisite for such loans is that the municipalities, or counties, provide guarantees that have been politically adopted and approved by the state through the county governor or the Ministry of Local Government and Regional Development."]
[null,"\nArticle 453 (e) CRR","(e)","Information about market or credit risk concentrations within the credit mitigation taken;","Since posted and received collateral for variation margin is only cash, KBN does not have any risk concentrations within the credit mitigation taken.  "]

{"sheet":"EU OV1","index":5,"n_rows":44,"n_cols":6,"rows_kept":44,"cut":false,"hidden":false,"merged":[[5,1,6,2],[4,3,4,4]]}
[]
[null,"EU OV1 – Overview of total risk exposure amounts"]
[null,"(amounts in NOK)"]
[]
[null,null,null,"Risk weighted exposure amounts (RWEAs)",null,"Total own funds requirements"]
[null,null,null,"a","b","c"]
[null,null,null,{"$f":"'EU KM1'!D6","v":"T"},"T-1",{"$f":"D7","v":"T"}]
[null,1,"Credit risk (excluding CCR)",74074312752.919998,73477686449.050003,5925945020.2335997]
[null,2,"Of which the standardised approach ",74074312752.919998,73477686449.059998,5925945020.2335997]
[null,3,"Of which the Foundation IRB (F-IRB) approach ",0,0,0]
[null,4,"Of which:  slotting approach",0,0,0]
[null,"EU 4a","Of which: equities under the simple riskweighted approach",0,0,0]
[null,5,"Of which the Advanced IRB (A-IRB) approach ",0,0,0]
[null,6,"Counterparty credit risk - CCR ",6926351787.7999992,4679828863.2299995,554108143.02399993]
[null,7,"Of which the standardised approach ",0,0,0]
[null,8,"Of which internal model method (IMM)",0,0,0]
[null,"EU 8a","Of which exposures to a CCP",83112130.730000004,63697962.299999997,6648970.4584000008]
[null,"EU 8b","Of which credit valuation adjustment - CVA",3424470815.75,2530177493.5700002,273957665.25999999]
[null,9,"Of which other CCR",3418768841.3199997,2085953407.3599992,273501507.30559999]
[null,10,"Not applicable",null,0]
[null,11,"Not applicable",null,0]
[null,12,"Not applicable",null,0]
[null,13,"Not applicable",null,0]
[null,14,"Not applicable",null,0]
[null,15,"Settlement risk ",0,0,0]
[null,16,"Securitisation exposures in the non-trading book (after the cap)",0,0,0]
[null,17,"Of which SEC-IRBA approach ",null,0,0]
[null,18,"Of which SEC-ERBA (including IAA)",null,0,0]
[null,19,"Of which SEC-SA approach ",null,0,0]
[null,"EU 19a","Of which 1250%",null,0,0]
[null,20,"Position, foreign exchange and commodities risks (Market risk)",0,0,0]
[null,21,"Of which the standardised approach ",0,0,0]
[null,22,"Of which IMA ",0,0,0]
[null,"EU 22a","Large exposures",0,0,0]
[null,23,"Operational risk",2373954547.1100001,2373954547.1129999,189916363.76880002]
[null,"EU 23a","Of which basic indicator approach ",2373954547.1100001,2373954547.1129999,189916363.76880002]
[null,"EU 23b","Of which standardised approach ",0,0,0]
[null,"EU 23c","Of which advanced measurement approach ",0,0,0]
[null,24,"Amounts below the thresholds for deduction (subject\nto 250% risk weight) (For information)",0,0,0]
[null,25,"Not applicable",null,0]
[null,26,"Not applicable",null,0]
[null,27,"Not applicable",null,0]
[null,28,"Not applicable",null,0]
[null,29,"Total",83374619087.830002,80531469859.393005,6669969527.0264006]

{"sheet":"EU KM1","index":6,"n_rows":51,"n_cols":8,"rows_kept":51,"cut":false,"hidden":false,"merged":[]}
[]
[null,"EU KM1 - Key metrics"]
[null,"(amounts in NOK)"]
[]
[null,null,null,"a","b","c","d","e"]
[null,null,null,"T","T-1","T-2","T-3","T-4"]
[null,null,"Available own funds (amounts)"]
[null,1,"Common Equity Tier 1 (CET1) capital ",15639046725.1,15298926001.41,14958997052.690001,14295543567.450001]
[null,2,"Tier 1 capital ",18030646725.099998,17690526001.41,17350597052.689999,16687143567.449999]
[null,3,"Total capital ",20030646725.099998,19690526001.41,19350597052.689999,18687143567.450001]
[null,null,"Risk-weighted exposure amounts",0,0,0,0]
[null,4,"Total risk-weighted exposure amount",83374619087.830002,80531469859.389999,83660765419.820007,81378220978.110001]
[null,null,"Capital ratios (as a percentage of risk-weighted exposure amount)",0,0,0]
[null,5,"Common Equity Tier 1 ratio (%)",0.18759999999999999,0.19,0.17879999999999999,0.1757]
[null,6,"Tier 1 ratio (%)",0.21629999999999999,0.21970000000000001,0.2074,0.2051]
[null,7,"Total capital ratio (%)",0.2402,0.2445,0.23130000000000001,0.2296]
[null,null,"Additional own funds requirements to address risks other than the risk of excessive leverage (as a percentage of risk-weighted exposure amount)"]
[null,"EU 7a","Additional own funds requirements to address risks other than the risk of excessive leverage (%) ",2.1999999999999992E-2,2.1999999999999992E-2,2.1999999999999992E-2,2.1999999999999992E-2]
[null,"EU 7b","     of which: to be made up of CET1 capital (percentage points)",2.2000000000000006E-2,2.2000000000000006E-2,2.2000000000000006E-2,2.2000000000000006E-2]
[null,"EU 7c","     of which: to be made up of Tier 1 capital (percentage points)",2.2000000000000006E-2,2.2000000000000006E-2,2.2000000000000006E-2,2.2000000000000006E-2]
[null,"EU 7d","Total SREP own funds requirements (%)",0.10199999999999999,0.10199999999999999,0.10199999999999999,0.10199999999999999]
[null,null,"Combined buffer requirement (as a percentage of risk-weighted exposure amount)"]
[null,8,"Capital conservation buffer (%)",2.5000000000050975E-2,2.500000000001552E-2,2.5000000000053785E-2,2.4999999999966209E-2]
[null,"EU 8a","Conservation buffer due to macro-prudential or systemic risk identified at the level of a Member State (%)",0,0,0,0]
[null,9,"Institution specific countercyclical capital buffer (%)",2.1060469213661521E-2,1.663959482142582E-2,1.2737454894568101E-2,1.1133577478471962E-2]
[null,"EU 9a","Systemic risk buffer (%)",4.1828845234497231E-2,4.2593113249659198E-2,4.1733192571446975E-2,4.152017974648127E-2]
[null,10,"Global Systemically Important Institution buffer (%)",0,0,0,0]
[null,"EU 10a","Other Systemically Important Institution buffer",1.000000000002039E-2,1.0000000000031043E-2,1.0000000000021516E-2,9.9999999999864832E-3]
[null,11,"Combined buffer requirement (%)",9.7889314448110179E-2,9.4232708071131585E-2,8.9470647465970832E-2,8.7653757224905926E-2]
[null,"EU 11a","Overall capital requirements (%)",0.19989999999999999,0.19620000000000001,0.1915,0.18970000000000001]
[null,12,"CET1 available after meeting the total SREP own funds requirements (%)",0,0,0,0]
[null,null,"Leverage ratio"]
[null,13,"Total exposure measure",475082692983.35999,459355268166.99268,463132797537.07001,448528338170]
[null,14,"Leverage ratio (%)",3.7999999999999999E-2,3.85E-2,3.7499999999999999E-2,3.7199999999999997E-2]
[null,null,"Additional own funds requirements to address the risk of excessive leverage (as a percentage of total exposure measure)"]
[null,"EU 14a","Additional own funds requirements to address the risk of excessive leverage (%) "]
[null,"EU 14b","     of which: to be made up of CET1 capital (percentage points)"]
[null,"EU 14c","Total SREP leverage ratio requirements (%)",0.03,0.03,0.03,0.03]
[null,null,"Leverage ratio buffer and overall leverage ratio requirement (as a percentage of total exposure measure)",0,0]
[null,"EU 14d","Leverage ratio buffer requirement (%)",0,0,0,0]
[null,"EU 14e","Overall leverage ratio requirements (%)",0.03,0.03,0.03,0.03]
[null,null,"Liquidity Coverage Ratio"]
[null,15,"Total high-quality liquid assets (HQLA) (Weighted value - average)",114113184204.10156,106190503374.02344,111505765568.62,101899994097.17999]
[null,"EU 16a","Cash outflows - Total weighted value ",175467023685.96246,108858401998.85001,81803638059.979996,128111549579.15199]
[null,"EU 16b","Cash inflows - Total weighted value ",131653437885.67857,68246306626.699997,88685187203.910004,97322073506.919998]
[null,16,"Total net cash outflows (adjusted value)",43866755921.490616,40612095372.150002,20450909515,32027887394.787998]
[null,17,"Liquidity coverage ratio (%)",2.6013999999999999,"261.48%","545.24%","318.16%"]
[null,null,"Net Stable Funding Ratio"]
[null,18,"Total available stable funding",418857215025.71002,396256182533.37,406154105590.54999,395208684182.40997]
[null,19,"Total required stable funding",224585419512.42999,222014612594.70999,217790564009.70001,214872455602.10001]
[null,20,"NSFR ratio (%)",1.865,1.7847999999999999,1.8649,1.8392999999999999]

{"sheet":"EU OVC","index":7,"n_rows":7,"n_cols":5,"rows_kept":7,"cut":false,"hidden":false,"merged":[]}
[]
[null,"Table EU OVC - ICAAP information"]
[]
[null,"Free format text boxes for disclosure on qualitative items"]
[null,"Legal basis ","Row number","Free format","Free format"]
[null,"Article 438(a) CRR","(a)","Approach to assessing the adequacy of the internal capital","KBN bases internal capital assessment on quantitative and qualitative assessment of all material risk categories. The risk categories are market risk (incl. liquidity risk), credit risk and operational risk and correspond to the risk categories of KBNs risk appetite framework. The capital assessment is complemented with a stress scenario analysis to control the potential risk that KBN is subject to. The assessment is produced annually, reviewed by internal audit and approved by the Board of Directors.\n(Board of Directors = management body in its supervisory function)"]
[null,"Article 438(c) CRR","(b)","Upon demand from the relevant competent authority, the result of the institution's internal capital adequacy assessment process","\nPublication of Finanstilsynet's decision on Pillar 2 requirements for individual banks - Finanstilsynet.no"]

{"sheet":"Table EU OVA","index":8,"n_rows":13,"n_cols":5,"rows_kept":13,"cut":false,"hidden":false,"merged":[]}
[]
[null,"Table EU OVA - Institution risk management approach"]
[null,"Free format text boxes for disclosure of qualitative information"]
[]
[]
[null,"Legal basis","Row number","Qualitative information - Free format","Qualitative information - Free format"]
[null,"Point (f) of Article 435(1) CRR","(a)","Disclosure of concise risk statement approved by the management body","See the Director’s Report (in the annual report 2022)"]
[null,"Point (b) of Article 435(1) CRR","(b) ","Information on the risk governance structure for each type of risk","KBNs state ownership, customer group and sector political role imply that KBN maintains a low to very low risk profile. The Board has determined KBNs overall risk appetite, which is divided into the following categories: market risk, liquidity risk, credit risk, capital risk and operational risk with associated risk appetite. Risk appetite is operationalised through defined limits for types and extent of risk exposure. \nRisk management and internal control are integrated into the banks strategy and business processes, and are adapted to the nature, scope and complexity of the risk exposure. The CEO is responsible for the implementation of risk management and internal control, and follows up and assesses changes in the banks risk exposure.\nRobust internal control is carried out as an integrated part of the business processes of the bank. Risk management is established in a structure based on three lines of defence that ensures systematic identification, assessment and monitoring of the risk in all parts of KBNs activities. The first line of defence carries out operational tasks and is responsible for managing and controlling that all the activities are carried out within the established limits, and in accordance with external and internal regulations. The second line of defence conducts independent risk assessments, controls and validates models and develops and prepares KBNs risk and compliance reporting. The second line of defence consists of financial controlling as well as the risk management and compliance functions. Internal audit (KPMG) constitutes KBNs third line of defence and is the Board’s independent control and confirmation body.  "]
[null,"Point (e) of Article 435(1) CRR","(c) ","Declaration approved by the management body on the adequacy of the risk management arrangements.","See the Director’s Report"]
[null,"Point (c) of Article 435(1) CRR","(d)","Disclosure on the scope and nature of risk disclosure and/or measurement systems. ","All positions and exposures are included in measurement systems and in the calculation of risk levels and limit utilisation (calculated daily).\n"]
[null,"Point (c) of Article 435(1) CRR","(e)","Disclose information on the main features of risk disclosure and measurement systems.","The risk management function monitors risk levels daily and ensures escalation according to internal guidelines. \nThe risk management function provides weekly and monthly reports to management and to the Board of Directors respectively, on developments in all significant risk measures and risk drivers, including reporting of any limit breaches. "]
[null," Point (a) of Article 435(1) CRR","(f)","Strategies and processes to manage risks for each separate category of risk.","KBN’s financial risk strategy describes the risk strategy for liquidity and market risk, and credit risk outside of the lending to customers. KBN’s credit risk strategy for lending describes the credit risk strategy for lending to customers. The strategies describe the business model, its entailing risks, risk mitigating strategies and risk limit requirements."]
[null,"Points (a) and (d) of Article 435(1) CRR","(g)","Information on the strategies and processes to manage, hedge and mitigate risks, as well as on the monitoring of the effectiveness of hedges and mitigants.","The Board of Directors sets the risk appetite and delegates risk appetite thresholds and risk appetite limits for all risk categories to the CEO. The CEO delegate risk appetite and risk limits to front office to be utilised in accordance with the defined business strategy. Utilisation of all risk limits and levels are measured daily and followed up by the risk management function who ensures escalation in accordance with the risk appetite framework and internal guidelines. For hedged risk the risk limits are set on a net basis to ensure monitoring of effectiveness of hedging. See template MRA, template CRA, Table EU LIQA and table EU ORA for information on specific risk categories."]

{"sheet":"Table EU OVB","index":9,"n_rows":11,"n_cols":5,"rows_kept":11,"cut":false,"hidden":false,"merged":[]}
[]
[null,"Table EU OVB - Disclosure on governance arrangements"]
[null,"Free format text boxes for disclosure of qualitative information"]
[]
[]
[null,"Legal basis","Row number","Free format","Free format"]
[null,"Point (a) of Article 435(2) CRR","(a)","The number of directorships held by members of the management body.","There are 8 members in the management body in its management function."]
[null,"Point (b) of Article 435(2) CRR","(b)","Information regarding the recruitment policy for the selection of members of the management body and their actual knowledge, skills and expertise.","Members of the management body in its management function are recruited and selected by professional and recognised standards of recruitment, including job analysis of the organisation’s capabilities and required skills of the relevant role, competence-based interviews, tests certified by Norway’s most recognised certification body DNV, standardised reference checks and background checks carried out by external professional services.\n"]
[null,"Point (c) of Article 435(2) CRR","(c)","Information on the diversity policy with regard of the members of the management body.","KBN’s general diversity policy as stated in the ESG policy is valid for recruitment and selection of members of the management body in its management function. This includes mandatory identification of both male and female candidates and emphasis on striving for diversity regarding work experience, education, geography, cultural background, age, functional impairment, orientation and non-work related experience. Certain educational backgrounds represent functional expertise in KBN and will need to be expected to be overrepresented."]
[null,"Point (d) of Article 435(2) CRR","(d)","Information whether or not the institution has set up a separate risk committee and the frequency of the meetings.","KBN has a separate risk committee of the Board of Director’s which meets approximately six times a year."]
[null,"Point (e) Article 435(2) CRR","(e)","Description on the information flow on risk to the management body. ","The management body in its management function receives a weekly risk report while the management body in its supervisory function receives a monthly risk report. The reports include developments of all significant risk measures and risk drivers, reporting of any breaches of risk limits and the monthly report also includes a risk assessment. Any breaches of risk limits are reported to the management body in its management function as soon as possible after the breach has been observed and to the management function in its supervisory function either as soon as possible after the breach has been observed or in the next monthly report depending on the severity of the breach. The reporting includes an assessment of the breach."]

{"sheet":"Template EU LI1","index":10,"n_rows":28,"n_cols":11,"rows_kept":28,"cut":false,"hidden":false,"merged":[]}
[]
[null,"Template EU LI1 - Differences between the accounting scope and the scope of prudential consolidation and mapping of financial statement categories with regulatory risk categories "]
[null,"(amounts in NOK)"]
[]
[null,null,"a","b","c","d","e","f","g",null,"a-b"]
[null," ","Carrying values as reported in published financial statements","Carrying values under scope of prudential consolidation","Carrying values of items",null,null,null,null,null,"Differences between columns (a) and (b) in template EU LI1"]
[null,null,null,null,"Subject to the credit risk framework","Subject to the CCR framework ","Subject to the securitisation framework","Subject to the market risk framework","Not subject to own funds requirements or subject to deduction from own funds"]
[null,"Deposits with credit institutions",39512000000,39512000000,9901892847.2216206,29610107152.778378,0,0,0,0,0]
[null,"Other money market deposits",0,0,0,0,0,0,0,0,0]
[null,"Instalment loans",324532000000,324532000000,324532000000,0,0,0,0,0,0]
[null,"Notes, bonds and other interest-bearing securities",109235000000,109235000000,109235000000,0,0,0,0,0,0]
[null,"Financial derivatives",16119000000,25521497964.69289,0,25319497964.69289,0,202000000,0,0,-9402497964.6928921]
[null,"Deferred tax asset",2885000000,2885000000,1652000000,0,0,0,1233000000,0,0]
[null,"Other assets",166000000,166000000,166000000,0,0,0,0,0,0]
[null,"Total assets",492450000000,501851497964.69287,445486892847.22162,54929605117.471268,0,202000000,1233000000,0,-9401497964.6928844]
[null,"Loans from credit institutions",6567000000,6567000000,0,6567000000,0,0,0,0,0]
[null,"Commercial paper",23377000000,23377000000,0,0,0,0,23377000000,0,0]
[null,"Senior securities issued",402553000000,402553000000,0,0,0,0,402553000000,0,0]
[null,"Financial derivatives",39070000000,39070000000,0,39070000000,0,0,0,0,0]
[null,"Other liabilities",56000000,56000000,0,0,0,0,56000000,0,0]
[null,"Current tax liabilities",0,0,0,0,0,0,0,0,0]
[null,"Deferred tax liabilities",0,0,0,0,0,0,0,0,0]
[null,"Pension liabilities",27000000,27000000,0,0,0,0,27000000,0,0]
[null,"Subordinated debt",1897000000,1897000000,0,0,0,0,1897000000,0,0]
[null,"Share capital",3895000000,3895000000,0,0,0,0,3895000000,0,0]
[null,"Additional Tier 1 capital",2392000000,2392000000,0,0,0,0,2392000000,0,0]
[null,"Retained earnings",12617000000,12617000000,0,0,0,0,12617000000,0,0]
[null,"Total debt/eq",492450000000,492450000000,0,45637000000,0,0,446814000000,0,0]

{"sheet":"Template EU LI2","index":11,"n_rows":19,"n_cols":7,"rows_kept":19,"cut":false,"hidden":false,"merged":[[5,2,6,2],[5,3,5,6]]}
[]
[null,"Template EU LI2 - Main sources of differences between regulatory exposure amounts and carrying values in financial statements "]
[null,"(amounts in NOK)"]
[]
[null,null,"a","b","c","d","e"]
[null,null,"Total","Items subject to "]
[null,null,null,"Credit risk framework","Securitisation framework ","CCR framework ","Market risk framework"]
[1,"Assets carrying value amount under the scope of prudential consolidation (as per template LI1)",500618497964.69287,445486892847.22162,54929605117.471268,0,202000000]
[2,"Liabilities carrying value amount under the scope of prudential consolidation (as per template LI1)",-45637000000,0,-45637000000,0,0]
[3,"Total net amount under the scope of prudential consolidation",454981497964.69287,445486892847.22162,9292605117.4712696,0,202000000]
[4,"Off-balance-sheet amounts",0,0,0,0,0]
[5,"Differences in valuations ",0,0,0,0,0]
[6,"Differences due to different netting rules, other than those already included in row 2",-2154000000,-3565000000,1411000000,0,0]
[7,"Differences due to consideration of provisions",0,0,0,0,0]
[8,"Differences due to the use of credit risk mitigation techniques (CRMs)",0,0,0,0,0]
[9,"Differences due to credit conversion factors",0,0,0,0,0]
[10,"Differences due to Securitisation with risk transfer",0,0,0,0,0]
[11,"Other differences",0,0,0,0,0]
[12,"Exposure amounts considered for regulatory purposes",452827497964.69287,441921892847.22162,10703605117.47127,0,202000000]

{"sheet":"Template EU LI3","index":12,"n_rows":12,"n_cols":9,"rows_kept":12,"cut":false,"hidden":true,"merged":[[6,1,7,1],[6,2,7,2],[6,3,6,7]]}
[]
[]
[null,"Template EU LI3 - Outline of the differences in the scopes of consolidation (entity by entity) "]
[]
[]
[null,"a","b","c","d","e","f","g","h"]
[null,"Name of the entity","Method of accounting consolidation","Method of prudential consolidation",null,null,null,null,"Description of the entity"]
[null,null,null,"Full consolidation","Proportional consolidation","Equity method","Neither consolidated nor deducted","Deducted"]
[null,"Entity A","Full consolidation","X",null,null,null,null,"Credit institution"]
[null,"Entity N","Full consolidation",null,"X",null,null,null,"Credit institution"]
[null,"Entity Z","Full consolidation",null,null,null,"X",null,"Insurance entity"]
[null,"Entity AA","Full consolidation",null,null,"X",null,null,"Immaterial leasing company"]

{"sheet":"Table EU CCA","index":13,"n_rows":54,"n_cols":6,"rows_kept":54,"cut":false,"hidden":false,"merged":[[2,3,2,4]]}
[null,"Template EU CCA: Main features of regulatory own funds instruments and eligible liabilities instruments"]
[null,"(amounts in NOK)"]
[null,null,null,"Additional Tier 1 (AT1) capital",null,"Tier 2 capital"]
[null,null,null,"NOK 1200000000 Perpetual Fixed Rate Callable Additional Tier 1 Securities","NOK 1200000000 Perpetual Floating Rate Callable Additional Tier 1 Securities","NOK 1200000000 Perpetual Floating Rate Callable Additional Tier 1 Securities"]
[null,1,"Issuer","Kommunalbanken AS","Kommunalbanken AS","Kommunalbanken AS"]
[null,2,"Unique identifier (eg CUSIP, ISIN or Bloomberg identifier for private placement)","INO0010794373","NO0010876774","NO0010760168"]
[null,"2a","Public or private placement","PP","PP","PP"]
[null,3,"Governing law(s) of the instrument","Norwegian","Norwegian","Norwegian"]
[null,"3a ","Contractual recognition of write down and conversion powers of resolution authorities"]
[null,null,"Regulatory treatment"]
[null,4,"    Current treatment taking into account, where applicable, transitional CRR rules","N/A","N/A","N/A"]
[null,5,"     Post-transitional CRR rules","AT1","AT1","Tier 2"]
[null,6,"     Eligible at solo/(sub-)consolidated/ solo&(sub-)consolidated","Solo","Solo","Solo"]
[null,7,"     Instrument type (types to be specified by each jurisdiction)","AT1","AT1","Tier 2"]
[null,8,"Amount recognised in regulatory capital or eligible liabilities  (Currency in million, as of most recent reporting date)",0.996,0.997,1]
[null,9,"Nominal amount of instrument ","NOK 1,200,000,000","NOK 1,200,000,000","NOK 2,000,000,000"]
[null,"EU-9a","Issue price",1,1,1]
[null,"EU-9b","Redemption price",1,1,1]
[null,10,"Accounting classification","Liability-fair value","Liability-fair value","Liability-fair value"]
[null,11,"Original date of issuance","2017-06-21","2020-06-17","2016-05-23"]
[null,12,"Perpetual or dated","Perpetual","Perpetual","Dated"]
[null,13,"     Original maturity date ","Perpetual","Perpetual","1933-05-23"]
[null,14,"Issuer call subject to prior supervisory approval","Yes","Yes","Yes"]
[null,15,"     Optional call date, contingent call dates and redemption amount ","2027-06-21","2025-06-21","2028-05-23"]
[]
[null,16,"     Subsequent call dates, if applicable","Coupons dates","Coupons dates","Coupons dates"]
[null,null,"Coupons / dividends"]
[null,17,"Fixed or floating dividend/coupon ","Fixed to float","Floating","Fixed"]
[]
[null,18,"Coupon rate and any related index ","3.26% to but excluding 21/6/27 3m NIBOR +1.50% from 21/6/27","3 month NIBOR +1.25%","3.02% (3.07% if rated AA)"]
[null,19,"Existence of a dividend stopper ","No","No","No"]
[null,"EU-20a","     Fully discretionary, partially discretionary or mandatory (in terms of timing)","Full discretionary","Full discretionary","Mandatory"]
[null,"EU-20b","     Fully discretionary, partially discretionary or mandatory (in terms of amount)","Full discretionary","Full discretionary","Mandatory"]
[null,21,"     Existence of step up or other incentive to redeem","No","No","No"]
[null,22,"     Noncumulative or cumulative","Noncumulative","Noncumulative","Noncumulative"]
[null,23,"Convertible or non-convertible","Non-convertible","Non-convertible","Non-convertible"]
[null,24,"     If convertible, conversion trigger(s)","N/A","N/A","N/A"]
[null,25,"     If convertible, fully or partially","N/A","N/A","N/A"]
[null,26,"     If convertible, conversion rate","N/A","N/A","N/A"]
[null,27,"     If convertible, mandatory or optional conversion","N/A","N/A","N/A"]
[null,28,"     If convertible, specify instrument type convertible into","N/A","N/A","N/A"]
[null,29,"     If convertible, specify issuer of instrument it converts into","N/A","N/A","N/A"]
[null,30,"Write-down features","Yes","Yes","No"]
[null,31,"     If write-down, write-down trigger(s)",5.1249999999999997E-2,5.1249999999999997E-2,"N/A"]
[null,32,"     If write-down, full or partial","Partial","Partial","N/A"]
[null,33,"     If write-down, permanent or temporary","N/A","N/A","N/A"]
[null,34,"        If temporary write-down, description of write-up mechanism","N/A","N/A","N/A"]
[null,"34a ","Type of subordination (only for eligible liabilities)","N/A","N/A","N/A"]
[null,"EU-34b","Ranking of the instrument in normal insolvency proceedings","N/A","N/A","N/A"]
[null,35,"Position in subordination hierarchy in liquidation (specify instrument type immediately senior to instrument)","Senior debt","Senior debt","Tier 2"]
[null,36,"Non-compliant transitioned features","No","No","No"]
[null,37,"If yes, specify non-compliant features","N/A","N/A","N/A"]
[null,"37a","Link to the full term and conditions of the instrument (signposting)","N/A","N/A","N/A"]
[null,"(1) Insert ‘N/A’ if the question is not applicable"]

{"sheet":"Table EU LIA","index":14,"n_rows":8,"n_cols":5,"rows_kept":8,"cut":false,"hidden":false,"merged":[]}
[]
[null,"Table EU LIA - Explanations of differences between accounting and regulatory exposure amounts"]
[null,"Free format text boxes for disclosure of qualitative information"]
[]
[]
[null,"Legal basis","Row number","Qualitative information - Free format"]
[null,"Article 436(b) CRR","(a)","Differences between columns (a) and (b) in template EU LI1","See template EU LI1, column (a-b)"]
[null,"Article 436(d) CRR","(b)","Qualitative information on the main sources of differences between the accounting and regulatoy scope of consolidation shown in template EU LI2","The scope of netting and collateral are different between regulatory and accounting. In accounting financial derivatives are not netted. Furthermore, accounting carrying amounts are based on different accounting policies (amortised cost, hedge accounting and fair value), while regulatory is according to fair value, and includes offsetting and potential future exposure as well as adjustment for collateral."]

{"sheet":"EU PV1","index":15,"n_rows":17,"n_cols":12,"rows_kept":17,"cut":false,"hidden":false,"merged":[]}
[]
[null,"Template EU PV1: Prudent valuation adjustments (PVA)"]
[null,"Fixed format"]
[null,"(amounts in NOK)"]
[null,"Category level AVA","Category level AVA","Category level AVA","Category level AVA","Category level AVA","Category level AVA","Category level AVA","Category level AVA","Category level AVA","Category level AVA","Category level AVA"]
[1,"Market price uncertainty"," -   ",31058783,110264622,56544425," -   "," -   ",4917118,103851033," -   ",103851033]
[2,"Not applicable"]
[3,"Close-out cost"," -   ",360993," -   "," -   "," -   ",1178063," -   ",1358559," -   ",1358559]
[4,"Concentrated positions"," -   "," -   "," -   "," -   "," -   "," [Not applicable] "," [Not applicable] "," -   "," -   "," -   "]
[5,"Early termination"," -   "," -   "," -   "," -   "," -   "," [Not applicable] "," [Not applicable] "," -   "," -   "," -   "]
[6,"Model risk"," -   "," -   "," -   "," -   "," -   "," -   "," -   "," -   "," -   "," -   "]
[7,"Operational risk"," -   ",4955721,4955721," -   "," -   "," [Not applicable] "," [Not applicable] ",9911441," -   ",9911441]
[8,"Not applicable"]
[9,"Not applicable"]
[10,"Future administrative costs"," -   ",15753946,15753946," -   "," -   "," -   "," -   ",31507892," -   ",31507892]
[11,"Not applicable"]
[12,"Total Additional Valuation Adjustments (AVAs)"," -   ",52129442,130974288,56544425," -   ",1178063,4917118,146628925," -   ",146628925]

{"sheet":"EU CC1","index":16,"n_rows":123,"n_cols":7,"rows_kept":123,"cut":false,"hidden":false,"merged":[]}
[]
[null,"Template EU CC1 - Composition of regulatory own funds"]
[null,"(amounts in NOK)"]
[]
[null,null,null,"(a}","(b)"]
[null,null,null,"Amounts","Source based on reference numbers/letters of the balance sheet under the regulatory scope of consolidation "]
[null,null,"Common Equity Tier 1 (CET1) capital:  instruments and reserves                                                                                       "]
[null,1,"Capital instruments and the related share premium accounts ",3894625000,"(h)",null,3894625000]
[null,null,"     of which: Instrument type 1",0,null,null,"No mapping to Reporting"]
[null,null,"     of which: Instrument type 2",0,null,null,"No mapping to Reporting"]
[null,null,"     of which: Instrument type 3",0,null,null,"No mapping to Reporting"]
[null,2,"Retained earnings ",12676793937.889999,null,null,12243056848]
[null,3,"Accumulated other comprehensive income (and other reserves)",0,null,null,0]
[null,"EU-3a","Funds for general banking risk",0,null,null,0]
[null,4,"Amount of qualifying items referred to in Article 484 (3) and the related share premium accounts subject to phase out from CET1 ",0,null,null,0]
[null,5,"Minority interests (amount allowed in consolidated CET1)",0,null,null,0]
[null,"EU-5a","Independently reviewed interim profits net of any foreseeable charge or dividend ",0,null,null,0]
[null,6,"Common Equity Tier 1 (CET1) capital before regulatory adjustments",16511504744.660189,null,null,16137681848]
[null,null,"Common Equity Tier 1 (CET1) capital: regulatory adjustments ",0]
[null,7,"Additional value adjustments (negative amount)",0,null,null,0]
[null,8,"Intangible assets (net of related tax liability) (negative amount)",-142703645.13,"(a) minus (d)",null,-142462891.06]
[null,9,"Not applicable",0]
[null,10,"Deferred tax assets that rely on future profitability excluding those arising from temporary differences (net of related tax liability where the conditions in Article 38 (3) are met) (negative amount)",0,null,null,0]
[null,11,"Fair value reserves related to gains or losses on cash flow hedges of financial instruments that are not valued at fair value",0,null,null,0]
[null,12,"Negative amounts resulting from the calculation of expected loss amounts ",0,null,null,0]
[null,13,"Any increase in equity that results from securitised assets (negative amount)",0,null,null,0]
[null,14,"Gains or losses on liabilities valued at fair value resulting from changes in own credit standing",304617065.41000003,null,null,757101950.25]
[null,15,"Defined-benefit pension fund assets (negative amount)",0,null,null,0]
[null,16,"Direct and indirect holdings by an institution of own CET1 instruments (negative amount)",0,null,null,0]
[null,17,"Direct, indirect and synthetic holdings of the CET 1 instruments of financial sector entities where those entities have reciprocal cross holdings with the institution designed to inflate artificially the own funds of the institution (negative amount)",0,null,null,0]
[null,18,"Direct, indirect and synthetic holdings by the institution of the CET1 instruments of financial sector entities where the institution does not have a significant investment in those entities (amount above 10% threshold and net of eligible short positions) (negative amount)",0,null,null,0]
[null,19,"Direct, indirect and synthetic holdings by the institution of the CET1 instruments of financial sector entities where the institution has a significant investment in those entities (amount above 10% threshold and net of eligible short positions) (negative amount)",0,null,null,0]
[null,20,"Not applicable",0]
[null,"EU-20a","Exposure amount of the following items which qualify for a RW of 1250%, where the institution opts for the deduction alternative",0,null,null,0]
[null,"EU-20b","     of which: qualifying holdings outside the financial sector (negative amount)",0,null,null,0]
[null,"EU-20c","     of which: securitisation positions (negative amount)",0,null,null,0]
[null,"EU-20d","     of which: free deliveries (negative amount)",0,null,null,0]
[null,21,"Deferred tax assets arising from temporary differences (amount above 10% threshold, net of related tax liability where the conditions in Article 38 (3) are met) (negative amount)",-1227863238.4300001,null,null,-1562676112.0699999]
[null,22,"Amount exceeding the 17,65% threshold (negative amount)",0,null,null,0]
[null,23,"     of which: direct, indirect and synthetic holdings by the institution of the CET1 instruments of financial sector entities where the institution has a significant investment in those entities",0,null,null,0]
[null,24,"Not applicable",0]
[null,25,"     of which: deferred tax assets arising from temporary differences",0,null,null,0]
[null,"EU-25a","Losses for the current financial year (negative amount)",-59914193.229999997,null,null,-754967736.5]
[null,"EU-25b","Foreseeable tax charges relating to CET1 items except where the institution suitably adjusts the amount of CET1 items insofar as such tax charges reduce the amount up to which those items may be used to cover risks or losses (negative amount)",0,null,null,0]
[null,26,"Not applicable",0]
[null,27,"Qualifying AT1 deductions that exceed the AT1 items of the institution (negative amount)",0,null,null,0]
[null,"27a","Other regulatory adjusments",0,null,null,0]
[null,28,"Total regulatory adjustments to Common Equity Tier 1 (CET1)",-1125864011.3800001,null,null,-1703004789.3799999]
[null,29,"Common Equity Tier 1 (CET1) capital ",15298926001.41,null,null,14295543567.450001]
[null,null,"Additional Tier 1 (AT1) capital: instruments",0]
[null,30,"Capital instruments and the related share premium accounts ",2391600000,"(i)",null,2391600000]
[null,31,"     of which: classified as equity under applicable accounting standards",0,null,null,0]
[null,32,"     of which: classified as liabilities under applicable accounting standards",0,null,null,0]
[null,33,"Amount of qualifying items referred to in Article 484 (4) and the related share premium accounts subject to phase out from AT1",0,null,null,0]
[null,"EU-33a","Amount of qualifying items referred to in Article 494a(1) subject to phase out from AT1",0,null,null,0]
[null,"EU-33b","Amount of qualifying items referred to in Article 494b(1) subject to phase out from AT1",0,null,null,0]
[null,34,"Qualifying Tier 1 capital included in consolidated AT1 capital (including minority interests not included in row 5) issued by subsidiaries and held by third parties ",0,null,null,0]
[null,35,"    of which: instruments issued by subsidiaries subject to phase out ",0,null,null,0]
[null,36,"   Additional Tier 1 (AT1) capital before regulatory adjustments",2391600000,null,null,2391600000]
[null,null,"Additional Tier 1 (AT1) capital: regulatory adjustments",0]
[null,37,"Direct and indirect holdings by an institution of own AT1 instruments (negative amount)",0,null,null,0]
[null,38,"Direct, indirect and synthetic holdings of the AT1 instruments of financial sector entities where those entities have reciprocal cross holdings with the institution designed to inflate artificially the own funds of the institution (negative amount)",0,null,null,0]
[null,39,"Direct, indirect and synthetic holdings of the AT1 instruments of financial sector entities where the institution does not have a significant investment in those entities (amount above 10% threshold and net of eligible short positions) (negative amount)",0,null,null,0]
[null,40,"Direct, indirect and synthetic holdings by the institution of the AT1 instruments of financial sector entities where the institution has a significant investment in those entities (net of eligible short positions) (negative amount)",0,null,null,0]
[null,41,"Not applicable",0]
[null,42,"Qualifying T2 deductions that exceed the T2 items of the institution (negative amount)",0,null,null,0]
[null,"42a","Other regulatory adjustments to AT1 capital",0,null,null,0]
[null,43,"Total regulatory adjustments to Additional Tier 1 (AT1) capital",0,null,null,0]
[null,44,"Additional Tier 1 (AT1) capital ",2391600000,null,null,2391600000]
[null,45,"Tier 1 capital (T1 = CET1 + AT1)",17690526001.41,null,null,16687143567.450001]
[null,null,"Tier 2 (T2) capital: instruments",0]
[null,46,"Capital instruments and the related share premium accounts",2000000000,null,null,2000000000]
[null,47,"Amount of qualifying  items referred to in Article 484 (5) and the related share premium accounts subject to phase out from T2 as described in Article 486 (4) CRR",0,null,null,0]
[null,"EU-47a","Amount of qualifying  items referred to in Article 494a (2) subject to phase out from T2",0,null,null,0]
[null,"EU-47b","Amount of qualifying  items referred to in Article 494b (2) subject to phase out from T2",0,null,null,0]
[null,48,"Qualifying own funds instruments included in consolidated T2 capital (including minority interests and AT1 instruments not included in rows 5 or 34) issued by subsidiaries and held by third parties ",0,null,null,0]
[null,49,"   of which: instruments issued by subsidiaries subject to phase out",0,null,null,0]
[null,50,"Credit risk adjustments",0,null,null,0]
[null,51,"Tier 2 (T2) capital before regulatory adjustments",2000000000,null,null,2000000000]
[null,null,"Tier 2 (T2) capital: regulatory adjustments ",0]
[null,52,"Direct and indirect holdings by an institution of own T2 instruments and subordinated loans (negative amount)",0,null,null,0]
[null,53,"Direct, indirect and synthetic holdings of the T2 instruments and subordinated loans of financial sector entities where those entities have reciprocal cross holdings with the institution designed to inflate artificially the own funds of the institution (negative amount)",0,null,null,0]
[null,54,"Direct and indirect holdings of the T2 instruments and subordinated loans of financial sector entities where the institution does not have a significant investment in those entities (amount above 10% threshold and net of eligible short positions) (negative amount)  ",0,null,null,0]
[null,"54a","Not applicable",0]
[null,55,"Direct and indirect holdings by the institution of the T2 instruments and subordinated loans of financial sector entities where the institution has a significant investment in those entities (net of eligible short positions) (negative amount)",0,null,null,0]
[null,56,"Not applicable",0]
[null,"EU-56a ","Qualifying eligible liabilities deductions that exceed the eligible liabilities items of the institution (negative amount)",0,null,null,0]
[null,"56b","Other regulatory adjusments to T2 capital",0,null,null,0]
[null,57,"Total regulatory adjustments to Tier 2 (T2) capital",0,null,null,0]
[null,58,"Tier 2 (T2) capital ",2000000000,null,null,2000000000]
[null,59,"Total capital (TC = T1 + T2)",19690526001.41,null,null,18687143567.450001]
[null,60,"Total risk exposure amount",80531469859.389999,null,null,81378220978.110001]
[null,null,"Capital ratios and requirements including buffers "]
[null,61,"Common Equity Tier 1",0.19,null,null,0.1757]
[null,62,"Tier 1",0.21970000000000001,null,null,0.2051]
[null,63,"Total capital",0.2445,null,null,0.2296]
[null,64,"Institution CET1 overall capital requirements",0.16120000000000001,null,null,0.1547]
[null,65,"of which: capital conservation buffer requirement ",2.5000000000000001E-2,null,null,2.4999999999966209E-2]
[null,66,"of which: countercyclical capital buffer requirement ",1.66E-2,null,null,1.1133577478471962E-2]
[null,67,"of which: systemic risk buffer requirement ",4.2599999999999999E-2,null,null,4.152017974648127E-2]
[null,"EU-67a","of which: Global Systemically Important Institution (G-SII) or Other Systemically Important Institution (O-SII) buffer requirement",0.01,null,null,9.9999999999864832E-3]
[null,"EU-67b","of which: additional own funds requirements to address the risks other than the risk of excessive leverage",2.1999999999999999E-2,null,null,2.2000000000000006E-2]
[null,68,"Common Equity Tier 1 capital (as a percentage of risk exposure amount) available after meeting the minimum capital requirements","-",null,null,{"$error":"#N/A"}]
[null,69,"Not applicable","-"]
[null,70,"Not applicable","-"]
[null,71,"Not applicable","-"]
[null,null,"Amounts below the thresholds for deduction (before risk weighting) "]
[null,72,"Direct and indirect holdings of own funds and eligible liabilities of financial sector entities where the institution does not have a significant investment in those entities (amount below 10% threshold  and net of eligible short positions)   ","-",null,null,0]
[null,73,"Direct and indirect holdings by the institution of the CET1 instruments of financial sector entities where the institution has a significant investment in those entities (amount below 17.65% thresholds and net of eligible short positions) ","-",null,null,0]
[null,74,"Not applicable"]
[null,75,"Deferred tax assets arising from temporary differences (amount below 17.65%  threshold, net of related tax liability where the conditions in Article 38 (3) are met)","-",null,null,0]
[null,null,"Applicable caps on the inclusion of provisions in Tier 2 "]
[null,76,"Credit risk adjustments included in T2 in respect of exposures subject to standardised approach (prior to the application of the cap)","-",null,null,0]
[null,77,"Cap on inclusion of credit risk adjustments in T2 under standardised approach","-",null,null,0]
[null,78,"Credit risk adjustments included in T2 in respect of exposures subject to internal ratings-based approach (prior to the application of the cap)","",null,null,""]
[null,79,"Cap for inclusion of credit risk adjustments in T2 under internal ratings-based approach"]
[null,null,"Capital instruments subject to phase-out arrangements (only applicable between 1 Jan 2014 and 1 Jan 2022)"]
[null,80,"Current cap on CET1 instruments subject to phase out arrangements","-",null,null,0]
[null,81,"Amount excluded from CET1 due to cap (excess over cap after redemptions and maturities)","-",null,null,0]
[null,82,"Current cap on AT1 instruments subject to phase out arrangements","-",null,null,0]
[null,83,"Amount excluded from AT1 due to cap (excess over cap after redemptions and maturities)","-",null,null,0]
[null,84,"Current cap on T2 instruments subject to phase out arrangements","-",null,null,0]
[null,85,"Amount excluded from T2 due to cap (excess over cap after redemptions and maturities)","-",null,null,0]

{"sheet":"EU CC2","index":17,"n_rows":15,"n_cols":4,"rows_kept":15,"cut":false,"hidden":false,"merged":[]}
[]
[null,"Template EU CC2 - reconciliation of regulatory own funds to balance sheet in the audited financial statements"]
[null,"(amounts in NOK)"]
[null,null,"a","b "]
[null,null,"Balance sheet as in published financial statements","Under regulatory scope of consolidation"]
[null,null,"As at period end","As at period end"]
[null,"Assets - Breakdown by asset classes according to the balance sheet in the published financial statements"]
[]
[null,"Deposits with credit institutions",39511960018.07058]
[null,"Other money market deposits",1.430511474609375E-6]
[null,"Installment loans",324532389641.59064]
[null,"Notes, bonds and other interest-bearing securities",109235387971.07951]
[null,"Financial derivatives",16119364446.958111]
[null,"Deferred tax asset",2885064930.5900002]
[null,"Other assets",166449885.70123991]

{"sheet":"EU CCYb1","index":18,"n_rows":19,"n_cols":16,"rows_kept":19,"cut":false,"hidden":false,"merged":[[5,14,6,14],[5,15,6,15],[5,3,5,4],[5,5,5,6],[5,7,6,7],[5,8,6,8],[5,12,6,12],[5,13,6,13]]}
[]
[]
[null,"Template EU CCyB1 - Geographical distribution of credit exposures relevant for the calculation of the countercyclical buffer"]
[null,"(amounts in NOK)"]
[null,null,null,"a","b","c","d","e","f","g","h","i","j","k","l","m"]
[null,null,null,"General credit exposures",null,"Relevant credit exposures – Market risk",null,"Securitisation exposures  Exposure value for non-trading book","Total exposure value","Own fund requirements",null,null," Total","Risk-weighted exposure amounts ","Own fund requirements weights\n(%)","Countercyclical buffer rate\n(%)"]
[null,null,null,"Exposure value under the standardised approach","Exposure value under the IRB approach","Sum of long and short positions of trading book exposures for SA","Value of trading book exposures for internal models",null,null,"Relevant credit risk exposures - Credit risk","Relevant credit exposures – Market risk","Relevant credit exposures – Securitisation positions in the non-trading book "]
[null,null,"Breakdown by country:"]
[null,null,"DENMARK",5395810437.7799997,0,0,0,0,5395810437.7799997,43166483.5,0,0,43166483.5,539581043.75,0.1235,0.02]
[null,null,"FINLAND",3321959443.8899999,0,0,0,0,3321959443.8899999,26575675.550000001,0,0,26575675.550000001,332195944.375,7.5999999999999998E-2,0]
[null,null,"FRANCE",8954934795.6499996,0,0,0,0,8954934795.6499996,3980720.1,0,0,3980720.1,49759001.25,1.14E-2,0]
[null,null,"GERMANY",402527054.31999999,0,0,0,0,402527054.31999999,3220216.43,0,0,3220216.43,40252705.375,9.1999999999999998E-3,0]
[null,null,"NETHERLANDS",310055291.81999999,0,0,0,0,310055291.81999999,2480442.33,0,0,2480442.33,31005529.125,7.1000000000000004E-3,0]
[null,null,"NORWAY",24234063503.040001,0,0,0,0,24234063503.040001,245117475.12,0,0,245117475.12,3063968439,0.70130000000000003,0.02]
[null,null,"SWEDEN",3052205241,0,0,0,0,3052205241,4202384.9800000004,0,0,4202384.9800000004,52529812.250000007,1.2E-2,0.01]
[null,null,"UNITED KINGDOM",104978138.63,0,0,0,0,104978138.63,839825.11,0,0,839825.11,10497813.875,2.3999999999999998E-3,0.01]
[null,null,"UNITED STATES",498765120,0,0,0,0,498765120,19950605,0,0,19950605,249382563,5.7099999999999998E-2,0]
[null,null,"…",null,null,null,null,null,null,null,null,null,null,null,0,0]
[null,null,"All countries",46275299026.129997,0,0,0,0,46275299026.129997,349533828.12,0,0,349533828.12,4369172851.5,0,0]

{"sheet":"EU CCYb2","index":19,"n_rows":8,"n_cols":9,"rows_kept":8,"cut":false,"hidden":false,"merged":[]}
[]
[null,"Template EU CCyB2 - Amount of institution-specific countercyclical capital buffer"]
[null,"(amounts in NOK)"]
[]
[null,null,null,"a",null,null,null,null,"a"]
[null,1,"Total risk exposure amount",80531469859.389999,null,null,1,"Total risk exposure amount",81378220978.110001]
[null,2,"Institution specific countercyclical capital buffer rate",1.66E-2,null,null,2,"Institution specific countercyclical capital buffer rate",1.1133577478471962E-2]
[null,3,"Institution specific countercyclical capital buffer requirement",1340011028.8399999,null,null,3,"Institution specific countercyclical capital buffer requirement",906030728.32000005]

{"sheet":"EU LR1","index":20,"n_rows":22,"n_cols":4,"rows_kept":22,"cut":false,"hidden":false,"merged":[]}
[]
[null,"Template EU LR1 - LRSum: Summary reconciliation of accounting assets and leverage ratio exposures"]
[null,"(amounts in NOK)"]
[]
[null,null,null,"a"]
[null,null,null,"Applicable amount"]
[null,1,"Total assets as per published financial statements",492450141602.98999]
[null,2,"Adjustment for entities which are consolidated for accounting purposes but are outside the scope of prudential consolidation",0]
[null,3,"(Adjustment for securitised exposures that meet the operational requirements for the recognition of risk transference)",0]
[null,4,"(Adjustment for temporary exemption of exposures to central banks (if applicable))",0]
[null,5,"(Adjustment for fiduciary assets recognised on the balance sheet pursuant to the applicable accounting framework but excluded from the total exposure measure in accordance with point (i) of Article 429a(1) CRR)",0]
[null,6,"Adjustment for regular-way purchases and sales of financial assets subject to trade date accounting",0]
[null,7,"Adjustment for eligible cash pooling transactions",0]
[null,8,"Adjustments for derivative financial instruments",-4737822378]
[null,9,"Adjustment for securities financing transactions (SFTs)",0]
[null,10,"Adjustment for off-balance sheet items (ie conversion to credit equivalent amounts of off-balance sheet exposures)",260307148.99999997]
[null,11,"(Adjustment for prudent valuation adjustments and specific and general provisions which have reduced Tier 1 capital)",0]
[null,"EU-11a","(Adjustment for exposures excluded from the total exposure measure in accordance with point (c ) of Article 429a(1) CRR)",0]
[null,"EU-11b","(Adjustment for exposures excluded from the total exposure measure in accordance with point (j) of Article 429a(1) CRR)",-1227863000]
[null,12,"Other adjustments",-27389496207]
[null,13,"Total exposure measure",459355267167]
[null,null,null,{"$f":"SUM(D7:D20)","v":459355267166.98999}]

{"sheet":"EU LR2","index":21,"n_rows":72,"n_cols":5,"rows_kept":72,"cut":false,"hidden":false,"merged":[[3,3,3,4],[6,1,6,2]]}
[]
[null,"EU LR2 - LRCom: Leverage ratio common disclosure"]
[null,"(amounts in NOK)"]
[null,null,null,"CRR leverage ratio exposures"]
[null,null,null,"a","b"]
[null,null,null,"T","T-1"]
[null,"On-balance sheet exposures (excluding derivatives and SFTs)"]
[null,1,"On-balance sheet items (excluding derivatives, SFTs, but including collateral)",466659252386.60999,467232690739.97998]
[null,2,"Gross-up for derivatives collateral provided where deducted from the balance sheet assets pursuant to the applicable accounting framework",0,0]
[null,3,"(Deductions of receivables assets for cash variation margin provided in derivatives transactions)",-22576449765.02,-31696533421.080002]
[null,4,"(Adjustment for securities received under securities financing transactions that are recognised as an asset)",0,0]
[null,5,"(General credit risk adjustments to on-balance sheet items)",0,0]
[null,6,"(Asset amounts deducted in determining Tier 1 capital)",0,0]
[null,7,"Total on-balance sheet exposures (excluding derivatives and SFTs) ",444082802621.58997,435536157318.89996]
[null,"Derivative exposures",null,0,0]
[null,8,"Replacement cost associated with SA-CCR derivatives transactions (ie net of eligible cash variation margin)",4809757808.5900002,12103597868.780001]
[null,"EU-8a","Derogation for derivatives: replacement costs contribution under the simplified standardised approach",0,0]
[null,9,"Add-on amounts for potential future exposure associated with  SA-CCR derivatives transactions ",6571784260.4899998,7784351648.8199997]
[null,"EU-9a","Derogation for derivatives: Potential future exposure contribution under the simplified standardised approach",0,0]
[null,"EU-9b","Exposure determined under Original Exposure Method",0,0]
[null,10,"(Exempted CCP leg of client-cleared trade exposures) (SA-CCR)",0,0]
[null,"EU-10a","(Exempted CCP leg of client-cleared trade exposures) (simplified standardised approach)",0,0]
[null,"EU-10b","(Exempted CCP leg of client-cleared trade exposures) (original Exposure Method)",0,0]
[null,11,"Adjusted effective notional amount of written credit derivatives",0,0]
[null,12,"(Adjusted effective notional offsets and add-on deductions for written credit derivatives)",0,0]
[null,13,"Total derivatives exposures ",11381542069.08,19887949517.599998]
[null,"Securities financing transaction (SFT) exposures",null,0,0]
[null,14,"Gross SFT assets (with no recognition of netting), after adjustment for sales accounting transactions",0,0]
[null,15,"(Netted amounts of cash payables and cash receivables of gross SFT assets)",3630414249.1599998,7341712627.8599997]
[null,16,"Counterparty credit risk exposure for SFT assets",0,15686169.1]
[null,"EU-16a","Derogation for SFTs: Counterparty credit risk exposure in accordance with Articles 429e(5) and 222 CRR ",0,0]
[null,17,"Agent transaction exposures",0,0]
[null,"EU-17a","(Exempted CCP leg of client-cleared SFT exposure)",0,0]
[null,18,"Total securities financing transaction exposures",3630414249.1599998,7357398796.96]
[null,"Other off-balance sheet exposures ",null,0,0]
[null,19,"Off-balance sheet exposures at gross notional amount",0,0]
[null,20,"(Adjustments for conversion to credit equivalent amounts)",260307149.29999998,0]
[null,21,"(General provisions deducted in determining Tier 1 capital and specific provisions associated with off-balance sheet exposures)","NOT mappable","NOT mappable"]
[null,22,"Off-balance sheet exposures",260307149.29999998,351291903.60000002]
[null,"Excluded exposures "]
[null,"EU-22a","(Exposures excluded from the leverage ratio total exposure measure in accordance with point (c ) of Article 429a(1) CRR)",0,0]
[null,"EU-22b","(Exposures exempted in accordance with point (j) of Article 429a (1) CRR (on and off balance sheet))",0,0]
[null,"EU-22c","(Excluded exposures of public development banks (or units) - Public sector investments)",0,0]
[null,"EU-22d"," (Excluded exposures of public development banks (or units) - Promotional loans)",0,0]
[null,"EU-22e","( Excluded passing-through promotional loan exposures by non-public development banks (or units))",0,0]
[null,"EU-22f","(Excluded guaranteed parts of exposures arising from export credits )",0,0]
[null,"EU-22g","(Excluded excess collateral deposited at triparty agents )",0,0]
[null,"EU-22h","(Excluded CSD related services of CSD/institutions in accordance with point (o) of Article 429a(1) CRR)",0,0]
[null,"EU-22i","(Excluded CSD related services of designated institutions in accordance with point (p) of Article 429a(1) CRR)",0,0]
[null,"EU-22j","(Reduction of the exposure value of pre-financing or intermediate loans )",0,0]
[null,"EU-22k","(Total exempted exposures)",0,0]
[null,"Capital and total exposure measure"]
[null,23,"Tier 1 capital",17687270479,17350597052.689999]
[null,24,"Total exposure measure",459355066089.12994,463132797537.05994]
[null,"Leverage ratio"]
[null,25,"Leverage ratio",3.8504572572991044E-2,3.7463546406042644E-2]
[null,"EU-25","Leverage ratio (excluding the impact of the exemption of public sector investments and promotional loans) (%)",3.8504572572991044E-2,3.7463546406042644E-2]
[null,"25a","Leverage ratio (excluding the impact of any applicable temporary exemption of\ncentral bank reserves)",3.8504572572991044E-2,3.7463546406042644E-2]
[null,26,"Regulatory minimum leverage ratio requirement (%)",0.03,0.03]
[null,"EU-26a","Additional own funds requirements to address the risk of excessive leverage (%) ",0,0]
[null,"EU-26b","     of which: to be made up of CET1 capital (percentage points)",0,0]
[null,27,"Leverage ratio buffer requirement (%)",0,0]
[null,"EU-27a","Overall leverage ratio requirement (%)",0.03,0.03]
[null,"Choice on transitional arrangements and relevant exposures"]
[null,"EU-27b","Choice on transitional arrangements for the definition of the capital measure"]
[null,"Disclosure of mean values"]
[null,28,"Mean value of gross SFT assets, after adjustment for sale accounting transactions and netted of amounts of associated cash payables and cash receivables",28406152.030000001]
[null,29,"Quarter-end value of gross SFT assets, after adjustment for sale accounting transactions and netted of amounts of associated cash payables and cash receivables"]
[null,30,"Total exposure measure (including the impact of any applicable temporary exemption of central bank reserves) "]
[null,"30a","Total exposure measure (excluding the impact of any applicable temporary exemption of central bank reserves) "]
[null,31,"Leverage ratio (including the impact of any applicable temporary exemption of central bank reserves) "]
[null,"31a","Leverage ratio (excluding the impact of any applicable temporary exemption of central bank reserves) "]

{"sheet":"EU LR3","index":22,"n_rows":17,"n_cols":11,"rows_kept":17,"cut":false,"hidden":false,"merged":[]}
[]
[null,"Template EU LR3 - LRSpl: Split-up of on balance sheet exposures (excluding derivatives, SFTs and exempted exposures)"]
[null,"(amounts in NOK)"]
[]
[null,null,null,null,"CRR leverage ratio exposures",null,null,null,null,null,"CRR leverage ratio exposures"]
[null,null,"EU-1","Total on-balance sheet exposures (excluding derivatives, SFTs, and exempted exposures), of which:",444083004699.45001,null,null,null,"EU-1","Total on-balance sheet exposures (excluding derivatives, SFTs, and exempted exposures), of which:",432544876075.59003]
[null,null,"EU-2","Trading book exposures",0,null,null,null,"EU-2","Trading book exposures",0]
[null,null,"EU-3","Banking book exposures, of which:",444083004699.45001,null,null,null,"EU-3","Banking book exposures, of which:",432544876075.59003]
[null,null,"EU-4","Covered bonds",29046379333.27,null,null,null,"EU-4","Covered bonds",30231093908.560001]
[null,null,"EU-5","Exposures treated as sovereigns",77891664745.990005,null,null,null,"EU-5","Exposures treated as sovereigns",76307017417.070007]
[null,null,"EU-6","Exposures to regional governments, MDB, international organisations and PSE not treated as sovereigns",326255945048.26001,null,null,null,"EU-6","Exposures to regional governments, MDB, international organisations and PSE not treated as sovereigns",312964677972.46997]
[null,null,"EU-7","Institutions",8689679952.1299992,null,null,null,"EU-7","Institutions",11405983276.280001]
[null,null,"EU-8","Secured by mortgages of immovable properties",21872351.989999998,null,null,null,"EU-8","Secured by mortgages of immovable properties",21742283.210000001]
[null,null,"EU-9","Retail exposures",0,null,null,null,"EU-9","Retail exposures",0]
[null,null,"EU-10","Corporates",498765120.26999998,null,null,null,"EU-10","Corporates",0]
[null,null,"EU-11","Exposures in default",0,null,null,null,"EU-11","Exposures in default",0]
[null,null,"EU-12","Other exposures (eg equity, securitisations, and other non-credit obligation assets)",1678698147.54,null,null,null,"EU-12","Other exposures (eg equity, securitisations, and other non-credit obligation assets)",1614361218]

{"sheet":"Table EU LRA","index":23,"n_rows":9,"n_cols":4,"rows_kept":9,"cut":false,"hidden":false,"merged":[[5,2,6,2]]}
[]
[null,"Table EU LRA: Disclosure of LR qualitative information"]
[]
[]
[]
[null,null,null,"a"]
[null,"Row",null,"Free format"]
[null,"(a)","Description of the processes used to manage the risk of excessive leverage","Due to KBN’s funding in foreign markets and currencies, a weaker NOK against other currencies will increase received collateral and reduce the leverage ratio. To manage the leverage ratio, KBN plans the maturity profile of short-term commercial paper (CP) funding to be able to counteract the effects of received collateral by redeeming maturing CP’s. KBN can also buy back issued bonds to reduce its balance sheet. KBN also maintains management buffers (both set by the Board of Directors and the CEO) to address sensitivity of the leverage ratio to fluctuations in the currency market."]
[null,"(b)","Description of the factors that had an impact on the leverage ratio during the period to which the disclosed leverage ratio refers","Weaker NOK during the autumn of 2022, reduced the leverage ratio due to received collateral and thus a larger liquidity portfolio.  "]

{"sheet":"Table EU LIQA","index":24,"n_rows":18,"n_cols":4,"rows_kept":18,"cut":false,"hidden":false,"merged":[[4,2,4,3],[13,3,17,3]]}
[]
[null,"Table EU LIQA - Liquidity risk management "]
[null,"in accordance with Article 451a(4) CRR"]
[]
[null,"Row number","Qualitative information - Free format"]
[null,"(a)","Strategies and processes in the management of the liquidity risk, including policies on diversification in the sources and tenor of planned funding, ","The aim of the liquidity strategy is to ensure proper liquidity management so that the bank has sufficient liquidity at all times to cover payment obligations when due. KBN'’s strategy is to keep a liquidity reserve in liquid securities with a high credit rating. The liquidity portfolio should be sufficiently large to be able to cover its liquidity outflow corresponding to previously experienced crises. The structure of the portfolio should be adapted to the strategic goals for liquidity management.\n\nLiquidity risk is managed by matching maturity profiles and interest rate reset periods for assets and liabilities. The policy requires that the liquidity portfolio must  at any time cover a minimum of 10 months' obligations, without access to new borrowing. The maturity of the liquidity portfolio is kept short, so that liquidity needs are mainly managed through maturity of the asset side. The liquidity portfolio is invested in liquid securities of very high credit quality."]
[null,"(b)","Structure and organisation of the liquidity risk management function (authority, statute, other arrangements).","KBN's risk management consists of structured processes to manage the liquidity risks to which KBN is exposed. Liquidity risks should be identified and assessed in relation to their materiality for KBN. Furthermore, there should be an appetite for material liquidity risks. A qualitative assessment of the actual risk level against the established risk appetite should be reported to the board regularly. Quantitative risk appetite thresholds and risk limits should be controlled daily. Models that measure liquidity risks should be validated. When doing work on or developing the bank’s business strategy, risks should be assessed against the established liquidity risk appetite. The CEO decides on the division of responsibilities regarding risk management processes between operative first line functions and the control function."]
[null,"(c)","A description of the degree of centralisation of liquidity management and interaction between the group’s units","The Chief Capital Markets Officer is responsible for ensuring that management of liquidity, credit and market risk is in accordance with the strategy and within the established risk appetite and delegated risk frameworks. The Chief Capital Markets Officer is responsible for ongoing daily monitoring of limits and risks, and that forecasts are prepared for important key figures. The Chief Capital Markets Officer should regularly inform KBN's board of directors about the market situation, risk conditions and returns from capital management."]
[null,"(d)","Scope and nature of liquidity risk reporting and measurement systems.","KBNs portfolio system contains all transaction contracts from assets, liabilities and derivatives (except loans to customers). This represents a complete basis for all liquidity risk in KBN. Daily risk and limit calculations are based on this system. Market risk sensitivities of these contracts are transferred from the portfolio system to a central data repository daily. Limit utilisation and liquidity risk levels are calculated daily based on the holdings in the central data repository."]
[null,"(e)","Policies for hedging and mitigating the liquidity risk and strategies and processes for monitoring the continuing effectiveness of hedges and mitigants.","KBN reduces unsystematic risk linked to the individual issuer by spreading the investments to many issuers within the classes of securities that are invested in. Systematic risk is common to the whole market or market segment and can only be reduced to a limited extent. KBN systematically diversifies risk to some extent through the geographical spread of the investment universe, and through holding different classes of securities (e.g., government securities, municipal bonds, covered bonds). For investments in bonds, the duration of the security is crucial for the size of the value change. KBN limits the size of the value changes by setting targets for the average maturity of the liquidity portfolio and a limit on the maximum maturity of individual investments.\nKBN hedges currency risk through the use of currency derivatives on both the debt and asset side. Currency risk is hedged back to the base currencies EUR, NOK and USD. These hedging transactions mean that the bank never takes asset net positions in other foreign currencies."]
[null,"(f)","An outline of the bank`s contingency funding plans.","Contingency funding plan actions: \n•\tSelling liquid assets\n•\tAdjusting the lending portfolio\n•\tIssuing subordinated debt\n•\tRaising equity\n•\tReducing dividend payments"]
[null,"(g)","An explanation of how stress testing is used.","Stress tests are used to assess how KBN's liquidity is likely to be affected in stress scenarios. Volatility in market risk factors is the most important driver of liquidity risk in KBN. A change in these factors is thus the main focus of the scenario. In addition, macroeconomic effects on municipal finances and thus developments in loan growth are included."]
[null,"(h)","A declaration approved by the management body on the adequacy of liquidity risk management arrangements of the institution providing assurance that the liquidity risk management systems put in place are adequate with regard to the institution’s profile and strategy.","See the Director’s Report"]
[null,"(i)","A concise liquidity risk statement approved by the management body succinctly describing the institution’s overall liquidity risk profile associated with the business strategy. This statement shall include key ratios and figures (other than those already covered in the EU LIQ1 template under this ITS ) providing external stakeholders with a comprehensive view of the institution’s management of liquidity risk, including how the liquidity risk profile of the institution interacts with the risk tolerance set by the management body.\n\nThese ratios may include:","See the Director’s Report"]
[null,null,"·         Concentration limits on collateral pools and sources of funding (both products and counterparties)"]
[null,null,"·         Customised measurement tools or metrics that assess the structure of the bank’s balance sheet or that project cash flows and future liquidity positions, taking into account off-balance sheet risks which are specific to that bank"]
[null,null,"·         Liquidity exposures and funding needs at the level of individual legal entities, foreign branches and subsidiaries, taking into account legal, regulatory and operational limitations on the transferability of liquidity"]
[null,null,"·         Balance sheet and off-balance sheet items broken down into maturity buckets and the resultant liquidity gaps"]

{"sheet":"EU LIQ1","index":25,"n_rows":47,"n_cols":11,"rows_kept":47,"cut":false,"hidden":false,"merged":[]}
[]
[]
[null,"Template EU LIQ1 - Quantitative information of LCR"]
[null,"(amounts in NOK)"]
[]
[]
[null,null,null,"a","b","c","d","e","f","g","h"]
[null,null,null,"Total unweighted value (average)",null,null,null,"Total weighted value (average)"]
[null,"EU 1a","Quarter ending on (DD Month YYY)",{"$f":"'EU KM1'!D6","v":"T"},"T-1 ","T-2","T-3",{"$f":"D9","v":"T"},"T-1 ","T-2","T-3"]
[null,"EU 1b","Number of data points used in the calculation of averages"]
[null,"HIGH-QUALITY LIQUID ASSETS"]
[null,1,"Total high-quality liquid assets (HQLA), after application of haircuts in line with Article 9 of regulation (EU) 2015/61",null,null,null,null,114113179892.14999,106190499983.25999,111505765568.62]
[null,"CASH - OUTFLOWS",null,null,null,null,null,null,null,0]
[null,2,"retail deposits and deposits from small business customers, of which:",0,0,0,null,null,null,0]
[null,3,"Stable deposits",0,0,0,null,null,null,0]
[null,4,"Less stable deposits",0,0,0,null,null,null,0]
[null,5,"Unsecured wholesale funding",18623981473.799999,19030310932.330002,2491151549.0900002,null,12286429959.49,12286429959.49,12286429959.49]
[null,6,"Operational deposits (all counterparties) and deposits in networks of cooperative banks",0,0,0,null,0,0,0]
[null,7,"Non-operational deposits (all counterparties)",0,0,0,null,0,0,0]
[null,8,"Unsecured debt",18623981473.799999,19030310932.330002,2491151549.0900002,null,12286429959.49,12286429959.49,12286429959.49]
[null,9,"Secured wholesale funding",{"$f":"Q22/1000000","v":0},0,0,null,0,0,0]
[null,10,"Additional requirements",161473289739.45999,92145116860.729996,81770538079.429993,null,155708149536.16,89815191066.529999,79016667197.029999]
[null,11,"Outflows related to derivative exposures and other collateral requirements",155067578402.45999,89556310422.729996,78710681543.429993,null,155067578402.45999,89556310422.729996,78710681543.429993]
[null,12,"Outflows related to loss of funding on debt products",0,0,0,null,0,0,0]
[null,13,"Credit and liquidity facilities",6405711337,2588806438,3059856536,null,640571133.70000005,258880643.80000001,305985653.60000002]
[null,14,"Other contractual funding obligations",0,0,0,null,0,0,0]
[null,15,"Other contingent funding obligations",1117392000,12900000,114000000,null,1117392000,12900000,114000000]
[null,16,"TOTAL CASH OUTFLOWS",0,0,0,null,175449523009.95999,108858401998.85001,81803638059.979996]
[null,"CASH - INFLOWS",null,0,0,0,null,null,null,0]
[null,17,"Secured lending (e.g. reverse repos)",15102439535.129999,2526199389.3000002,7301350001.7600002,null,1537452761.25,279280411.43000001,511094500.12]
[null,18,"Inflows from fully performing exposures",2345569755.9299998,2366309766,4476360459.3699999,null,1172784877.97,1183154883,2238180229.6900001]
[null,19,"Other cash inflows",129424013347.69,66783871332.279999,85935912474.110001,null,129424013347.69,66783871332.279999,85935912474.110001]
[null,"EU-19a","(Difference between total weighted inflows and total weighted outflows arising from transactions in third countries where there are transfer restrictions or which are denominated in non-convertible currencies)",0,0,0,null,null,null,0]
[null,null,null,0,0,0,null,null,null,0]
[null,"EU-19b","(Excess inflows from a related specialised credit institution)",0,0,0,null,null,null,0]
[null,null,null,0,0,0,null,null,null,0]
[null,20,"TOTAL CASH INFLOWS",146872022638.75,71676380487.580002,97713622935.240005,null,132134250986.91,68246306626.699997,88685187203.910004]
[null,"EU-20a","Fully exempt inflows",0,0,0,null,0,0,0]
[null,null,null,null,null,0,null,null,null,0]
[null,"EU-20b","Inflows subject to 90% cap",0,0,0,null,0,0,0]
[null,null,null,null,null,0,null,null,null,0]
[null,"EU-20c","Inflows subject to 75% cap",146872022638.75,71676380487.580002,97713622935.240005,null,132134250986.91,68246306626.699997,88685187203.910004]
[null,null,null,null,null,null,null,null,null,0]
[null,"TOTAL ADJUSTED VALUE ",null,null,null,null,null,null,null,0]
[null,21,"LIQUIDITY BUFFER",null,null,null,null,114113184204.10156,106190499983.25999,111505765568.62]
[null,22,"TOTAL NET CASH OUTFLOWS",null,null,null,null,43862381000,40612095372.150002,20450909515]
[null,23,"LIQUIDITY COVERAGE RATIO",null,null,null,null,2.6013999999999999,2.6147999999999998,5.4523999999999999]

{"sheet":"EU LIQB","index":26,"n_rows":12,"n_cols":4,"rows_kept":12,"cut":false,"hidden":false,"merged":[[4,2,4,3]]}
[]
[null,"Table EU LIQB  on qualitative information on LCR, which complements template EU LIQ1."]
[null,"in accordance with Article 451a(2) CRR"]
[null,"(amounts in NOK)"]
[null,"Row number","Qualitative information - Free format"]
[null,"(a)","Explanations on the main drivers of LCR results and the evolution of the contribution of inputs to the LCR’s calculation over time","The holdings in KBN’s liquidity portfolio are primarily denominated in foreign currencies, meaning that fluctuations in the NOK exchange rate lead to fluctuations in KBN’s liquidity reserves when translated into NOK. Another major risk driver is how KBN ensures maturity of cash flows within 30 days when rolling FX-swaps and debt maturities. Other main risk drivers are credit spreads, interest rates and basis spreads. "]
[null,"(b)","Explanations on the changes in the LCR over time","Exchange rates, basis spreads, interest rates and credit spreads. "]
[null,"(c)","Explanations on the actual concentration of funding sources","The funding portfolio is split into four main groups, based on the funding product and loan documentation used. The four main categories are public (quoted) USD and EUR benchmark loans, loans in public niche markets, private placements and retail loans. The two first groups are characterised by listed syndicated loans in various currencies, where the size of the loan forms the primary difference between the two groups.\nKBN’s AAA/Aaa credit rating ensures it has stable access to funding on favorable terms, which benefits the local government sector. KBN pursues a diversified funding strategy that ensures it has a broad investor base and low refinancing risk.\nEurope, the US and Asia are KBN’s most important markets for funding. KBN has continued the approach it has followed in recent years of focusing more on simple, non-structured bonds with fixed or floating rates. Bonds of this type represented more than 92% of KBN’s issues in 2022. "]
[null,"(d)","High-level description of the composition of the institution`s liquidity buffer.","KBN has a portfolio of highly liquid securities. These holdings shall be transferrable to cash without significant losses for KBN under severely stressed market conditions, either through direct sales or through the use of repurchase agreements in a recognised repurchase market.\nThe liquidity portfolio shall have low credit and market risk and is invested in notes and bonds issued by sovereigns, local authorities, multilateral development banks and highly rated financial institutions."]
[null,"(e)","Derivative exposures and potential collateral calls","KBN uses derivatives contracts to manage the interest rate risk and exchange rate risk associated with its lending and funding activities and its liquidity portfolio investments. The counterparty risk associated with entering into derivative contracts is controlled by the use of central counterparties (clearing) or other counterparties with a high credit rating, and by exchanging collateral on a daily basis."]
[null,"(f)","Currency mismatch in the LCR","Currency mismatch in the LCR for KBN is mainly due to KBN financing most of the debt in other currencies than NOK and the majority of the asset side being denominated in NOK."]
[null,"(g)","Other items in the LCR calculation that are not captured in the LCR disclosure template but that the institution considers relevant for its liquidity profile"," All relevant items are captured in the LCR disclosure template. "]

{"sheet":"EU LIQ2","index":27,"n_rows":57,"n_cols":13,"rows_kept":57,"cut":false,"hidden":false,"merged":[[27,12,28,12],[6,12,7,12],[27,1,27,2],[27,5,27,11],[5,3,5,4],[6,1,6,2],[6,5,6,11],[6,3,7,4],[27,3,28,4]]}
[]
[null,"Template EU LIQ2: Net Stable Funding Ratio "]
[null,"In accordance with Article 451a(3) CRR"]
[null,"(amounts in NOK)"]
[null,"ASF"]
[null,null,null,null,null,"a",null,"b",null,"c",null,"d","e"]
[null,"C 81.00",null,null,null,"Unweighted value by residual maturity",null,null,null,null,null,null,"Weighted value"]
[null,"Ref BCBS NSFR","Ref CRR2",null,null,"No maturity[1]",null,"< 6 months",null,"6 months to < 1yr",null,"≥ 1yr"]
[]
[null,null,"451a 3b","Available stable funding (ASF) Items"]
[null,null,"See instructions",1,"Capital items and instruments",17687270479,null,0,null,0,null,2000000000,19687270479]
[null,"21a,24d, 25a",null,2,"Own funds",17687270479,null,0,null,0,null,2000000000,19687270479]
[null,"21b,24d,25a",null,3,"Other capital instruments",0,null,0,null,0,null,0,0]
[null,null,null,4,"Retail deposits",0,null,0,null,0,null,0,0]
[null,"21c,22",null,5,"Stable deposits",0,null,0,null,0,null,0,0]
[null,"21c,23",null,6,"Less stable deposits",0,null,0,null,0,null,0,0]
[null,null,null,7,"Wholesale funding:",0,null,58128370175.699997,null,41020769753.529999,null,326994342089.76001,376568912054.38]
[null,"21c,24b,25a",null,8,"Operational deposits",0,null,0,null,0,null,0,0]
[null,"21c,24acd,25a",null,9,"Other wholesale funding",0,null,58128370175.699997,null,41020769753.529999,null,326994342089.76001,376568912054.38]
[null,45,null,10,"Interdependent liabilities",0,null,0,null,0,null,0,0]
[null,null,null,11,"Other liabilities: ",0,null,17406872.879999999,null,0,null,0,17406872.879999999]
[null,"19,20,25c",null,12,"NSFR derivative liabilities ",0,null,0,null,0,null,0,0]
[null,"25abd",null,13,"All other liabilities and capital instruments not included in the above categories",0,null,17406872.879999999,null,0,null,0,0]
[null,null,null,14,"Total available stable funding (ASF)",0,null,0,null,0,null,0,396256182533.37]
[]
[null,"RSF"]
[null,null,null,null,null,"a",null,"b",null,"c",null,"d","e"]
[null,"C 80.00",null,null,null,"Unweighted value by residual maturity",null,null,null,null,null,null,"Weighted value"]
[null,"Ref BCBS NSFR","Ref CRR2",null,null,"No maturity[1]",null,"< 6 months",null,"6 months to < 1yr",null,"≥ 1yr"]
[]
[null,null,"451a 3c","Required stable funding (RSF) Items"]
[null,"36ab,37,39a,40ab,42a,43a","See instructions",15,"Total high-quality liquid assets (HQLA)",null,null,0,null,0,null,0,4126592688.1100006]
[null,null,null,"EU-15a","Assets encumbered for a residual maturity of one year or more in a cover pool",null,null,0,null,0,null,0,0]
[null,"40d",null,16,"Deposits held at other financial institutions for operational purposes",null,null,6037477763.6899996,null,0,null,0,3018738881.8499999]
[null,null,null,17,"Performing loans and securities:",null,null,19179693091.950001,null,13109952378,null,299751554025,209530960103.64999]
[null,"38,40c,43c",null,18,"Performing securities financing transactions with financial customerscollateralised by Level 1 HQLA subject to 0% haircut",null,null,0,null,0,null,0,0]
[null,"39b,40c,43c",null,19,"Performing securities financing transactions with financial customer collateralised by other assets and loans and advances to financial institutions",null,null,0,null,0,null,0,0]
[null,"36c,40e,41b,42b,43a",null,20,"Performing loans to non- financial corporate clients, loans to retail and small business customers, and loans to sovereigns, and PSEs, of which:",null,null,15548761223,null,13109952378,null,299751554025,209167866916.75]
[null,"36c,40e,41b,43a",null,21,"With a risk weight of less than or equal to 35% under the Basel II Standardised Approach for credit risk",null,null,15548761223,null,13109952378,null,299751554025,209167866916.75]
[null,"40e,41a,42b,43a",null,22,"Performing residential mortgages, of which: ",null,null,0,null,0,null,0,0]
[null,"40e,41a,43a",null,23,"With a risk weight of less than or equal to 35% under the Basel II Standardised Approach for credit risk",null,null,0,null,0,null,0,0]
[null,"40e,42c,43a",null,24,"Other loans and securities that are not in default and do not qualify as HQLA, including exchange-traded equities and trade finance on-balance sheet products",null,null,3630931868.9499998,null,0,null,0,363093186.89999998]
[null,45,null,25,"Interdependent assets",null,null,0,null,0,null,0,0]
[null,null,null,26,"Other assets: ",null,null,0,null,0,null,3048024714.1100001,5338320921.1100006]
[null,"42d",null,27,"Physical traded commodities",null,null,0,null,0,null,0,0]
[null,"42a ",null,28,"Assets posted as initial margin for derivative contracts and contributions to default funds of CCPs",null,null,0,null,0,null,0,2290296207]
[null,"34,35,43b",null,29,"NSFR derivative assets ",null,null,0,null,0,null,0,0]
[null,"19,43d",null,30,"NSFR derivative liabilities before deduction of variation margin posted ",null,null,0,null,0,null,0,0]
[null,"36d,43c",null,31,"All other assets not included in the above categories",null,null,0,null,0,null,3048024714.1100001,3048024714.1100001]
[null,"46,47",null,32,"Off-balance sheet items",null,null,0,null,0,null,0,0]
[null,null,null,33,"Total RSF",null,null,0,null,0,null,0,222014612594.70999]
[]
[]
[]
[null,"NSFR"]
[]
[null,9,"Art451a(3a), Art428b",34,"Net Stable Funding Ratio (%)",null,null,null,null,null,null,null,1.7847999999999999]

{"sheet":"Table EU CRA","index":28,"n_rows":8,"n_cols":4,"rows_kept":8,"cut":false,"hidden":false,"merged":[[2,1,2,18]]}
[]
[null,"Table EU CRA: General qualitative information about credit risk"]
[null,"Institutions shall describe their risk management objectives and policies for credit risk by providing the following information:"]
[null,null,"Qualitative disclosures"]
[null,"(a)","In the concise risk statement in accordance with point (f) of Article 435(1) CRR, how the business model translates into the components of the institution’s credit risk profile.","KBNs assets consist of loans to municipalities and similar, and a liquidity portfolio of commercial paper and bonds issued by or guaranteed by sovereigns, regional authorities, multilateral development banks, covered bonds and financial institutions with high credit rating.\nCredit risk arising from loans to customers is limited to payment deferrals as the payment obligation cannot be waived. The Local Government Act states that municipalities and similar cannot be declared bankrupt. In the Local Government Act, provisions have also been made on the procedures to be followed if payment deferral must be implemented. According to these provisions, the Ministry takes over the control of a municipality if the municipal council adopts payment deferrals. KBN does, however, perform credit assessment of all lending customers, based on a model for economic analysis of municipalities and similar. The model considers the municipalities’ financial situation with both qualitative and quantitative key indicators for economic development and prospects of the customer.\nKBN also grants loans to companies that perform tasks for municipalities and county municipalities. The prerequisite for such loans is that the municipalities, or county municipalities, provide guarantees that have been politically adopted and approved by the state through the chief county executive or the Ministry of Local Government and Regional Development.\nFinancial counterparties in the liquidity portfolio are subject to regular credit assessment and are allocated a credit limit. Credit limits are determined through an internal assessment of the counterparty’s rating, the banks risk capital, the type of financial instrument and its maturity.\nFor investments in Commercial paper and bonds, as well as for financial derivatives, the minimum rating requirement is A3/A- from Moody’s and Standard and Poor’s. \nKBN enters into derivative transactions in order to control interest rate and currency risk. Counterparties in derivative transactions are financial institutions or central counterparties. In addition to strict rating requirements, the risk inherent in derivative transactions is mitigated through the use of ISDA agreements (offsetting). Such agreements, that include the exchange of cash collateral, have been made with all derivative counterparties. \nKBN uses clearing services at a central counterparty (London Clearing House—LCH) for financial derivaties related to interest rate risk. As a central counterparty, LCH are subject to capital and risk management and are considered to have lower counterparty risk than ordinary financial institutions.\nKBN does not have a direct membership at LCH, and uses clearing brokers that act on behalf of KBN towards LCH. KBN has chosen to segregate its derivative positions and funds (collateral) in relation to any possible default of the clearing broker. Thus, the banks exposure is directly against LCH. KBN achieves a high degree of protection through such a solution. \nCredit risk related to the liquidity portfolio is low. The average rating of the portfolio is AA+ (based on the lowest of S&P and Moody’s) at 31 December 2022, and 68 per cent of the portfolio is invested in securities with a risk weight of zero per cent.  Average time to maturity of the portfolio was 1.7 years as of 31 December 2022. The risk in the portfolio is managed at issuer level and is limited due to the portfolios short duration."]
[null,"(b)","When discussing their strategies and processes to manage credit risk and the policies for hedging and mitigating that risk in accordance with points (a) and (d) of Article 435(1) CRR, the criteria and approach used for defining the credit risk management policy and for setting credit risk limits.","KBN’s policies for credit risk include large exposure limits on loan counterparties, investment counterparties and derivative counterparties to prevent concentration risk.\nDaily monitoring of the investment portfolio. \nDaily exchange of collateral (cash) on all derivatives to reduce unhedged credit risk on derivative exposure."]
[null,"(c)","When informing on the structure and organisation of the risk management function in accordance with point (b) of Article 435(1) CRR, the structure and organisation of the credit risk management and control function.","KBN's risk management consists of structured processes to manage the credit risks to which KBN is exposed. Credit risks should be identified and assessed in relation to their materiality for KBN. Furthermore, there should be an appetite for material credit risks. A qualitative assessment of the actual risk level in relation to established risk appetite should be reported to the board regularly. Quantitative risk appetite thresholds and risk frameworks should be controlled daily. Models that measure credit risks should be validated. When doing work on or developing the bank’s business strategy, risks should be assessed against the established credit risk appetite. The CEO decides on the division of responsibilities regarding risk management processes between operative first line functions and the control function. "]
[null,"(d)","When informing on the authority, status and other arrangements for the risk management function in accordance with point (b) of Article 435(1) CRR, the relationships between credit risk management, risk control, compliance and internal audit functions.","See table EU CRA c). "]

{"sheet":"Table EU CRB","index":29,"n_rows":8,"n_cols":4,"rows_kept":8,"cut":false,"hidden":false,"merged":[]}
[]
[null,"Table EU CRB: Additional disclosure related to the credit quality of assets"]
[]
[null,null,"Qualitative disclosures"]
[null,"(a)","The scope and definitions of ‘past-due’ and ‘impaired’ exposures used for accounting purposes and the differences, if any, between the definitions of past due and default for accounting and regulatory purposes as specified by the EBA Guidelines  on the application of the definition of default in accordance with Article 178 CRR.","At each reporting date, an allocation to stages 1, 2 or 3 is performed for all Loans to customers and Commercial paper and bonds that are measured at amortised cost.\n \nAll assets are allocated to stage 1 at initial recognition. On subsequent reporting dates, stage 1 allocation means that there has been no significant increase in credit risk since initial recognition for that particular asset. An allocation to stage 2 on a subsequent reporting date represents a significant increase in credit risk since initial recognition, while stage 3 implies that the asset is credit impaired. Stage 1 requires the calculation of a 12-month expected credit loss that is recognised in the Income statement and Statement of financial position. Assets allocated to stages 2 and 3 require the calculation of a lifetime expected credit loss, which also will be recognised in the Income statement and Statement of financial position. Actual credit losses have never taken place during KBNs history. \n \nThe recognition of interest income for assets allocated to stages 1 and 2 is based on the assets principal amount, while the recognition of interest income for assets allocated to stage 3 is based on the assets amortised cost, meaning after deduction of the provision for the expected credit loss. Expected credit loss is calculated per loan/instrument, based on exposure at default, probability of default and loss given default, all estimated at the reporting date.\n \nKBN uses three different scenarios in its model for the calculation of expected credit loss. Furthermore, the normalized values for probability of default are adjusted for market cycles in line with current market conditions at reporting times. The periods change in total expected credit loss is recognised in the Income statement as “Expected credit loss”. Within stage 1 a 12-month probability of default and lifetime losses based on default within the next 12 months are used, while stages 2 and 3 use lifetime probability of default and losses resulting from this.\n \nMajor changes in the issuers rating or a significant move under KBNs internal credit rating assessment are used as indicators of significant increase in credit risk since initial recognition. These will lead to an allocation of the asset to stage 2. For lending customers, consideration shall be given to whether such deterioration has taken place if a payment stop is decided under the Municipality Act. An assessment as credit impaired or allocation to stage 3 for loans to customers includes events that result in actual credit losses, or payment delays of at least 90 days over a certain threshold amount. For Commercial paper and bonds this will be triggered by events such as late payment, bankruptcy or restructuring due to financial problems."]
[null,"(b)","The extent of past-due exposures (more than 90 days) that are not considered to be impaired and the reasons for this.","No credit losses observed in the bank's history. No exposures past due longer than 90 days as at 31 December 2022."]
[null,"(c)","Description of methods used for determining general and specific credit risk adjustments.","N/A"]
[null,"(d)","The institution’s own definition of a restructured exposure used for the implementation of point (d) of Article 178(3) CRR specified by the EBA Guidelines  on defaultin accordance with Article 178 CRR when different from the definition of forborne exposure defined in Annex V to Commission Implementing Regulation (EU) 680/2014.","N/A  "]

{"sheet":"EU CR1-A","index":30,"n_rows":9,"n_cols":9,"rows_kept":9,"cut":false,"hidden":false,"merged":[]}
[]
[null,"Template EU CR1-A: Maturity of exposures"]
[null,"(amounts in NOK)"]
[null,null,null,"a","b","c","d","e","f"]
[null,null,null,"Net exposure value"]
[null,null,null,"On demand","<= 1 year","> 1 year <= 5 years","> 5 years","No stated maturity","Total"]
[null,1,"Loans and advances",0,6481942710.0599995,172139115433.2858,0,0,178621058143.34583]
[null,2,"Debt securities",6037477763.6899996,182181183519.70654,76772108436.779984,0,0,264990769720.17651]
[null,3,"Total",6037477763.6899996,188663126229.76654,248911223870.0658,0,0,443611827863.52228]

{"sheet":"Table EU CRD","index":31,"n_rows":7,"n_cols":5,"rows_kept":7,"cut":false,"hidden":false,"merged":[[1,1,1,3]]}
[]
[null,"Table EU CRD – Qualitative disclosure requirements related to standardised approach"]
[null,"Legal basis","Row number","Qualitative information - Free format","Qualitative information - Free format"]
[null,"Article 444  (a) CRR","(a)","Names of the external credit assessment institutions (ECAIs) and export credit agencies (ECAs) nominated by the institution, and the reasons for any changes over the disclosure period;","S&P Global Ratings\nMoody’s"]
[null,"Article 444  (b) CRR","(b)","The exposure classes for which each ECAI or ECA is used;","Central governments or central banks: S&P Global Ratings and Moody’s\nRegional governments or local authorities: S&P Global Ratings and Moody’s\nPublic sector entities: S&P Global Ratings and Moody’s\nMultilateral development banks: S&P Global Ratings and Moody’s\nInternational organisations: S&P Global Ratings and Moody’s\nInstitutions: S&P Global Ratings and Moody’s\nCorporates: S&P Global Ratings and Moody’s"]
[null,"Article 444 (c) CRR","(c )","A description of the process used to transfer the issuer and issue credit ratings onto comparable assets  items not included in the trading book;","Un-rated Norwegian municipalities are set to AA rating in supervisory capital adequacy calculations."]
[null,"Article 444 (d) CRR","(d)","The association of the external rating of each nominated ECAI or ECA  (as referred to in row (a)) with the risk weights that correspond with the credit quality steps as set out in Chapter 2 of Title II of Part Three CRR (except where the institution complies with the standard association published by the EBA).","KBN complies with the standard association published by the EBA."]

{"sheet":"EU CR4","index":32,"n_rows":24,"n_cols":9,"rows_kept":24,"cut":false,"hidden":false,"merged":[]}
[]
[null,"Template CR4 – standardised approach – Credit risk exposure and CRM effects"]
[null,"(amounts in NOK)"]
[]
[null,null,null,"Exposures before CCF and before CRM",null,"Exposures post CCF and post CRM",null,"RWAs and RWAs density"]
[null,null," Exposure classes","On-balance-sheet exposures","Off-balance-sheet exposures","On-balance-sheet exposures","Off-balance-sheet exposures","RWEA","RWEA density (%) "]
[null,null,null,"a","b","c","d","e","f"]
[null,1,"Central governments or central banks",23299277222.32,0,42196444759.75,0,0,0]
[null,2,"Regional government or local authorities",331959781297.52002,2591659449,346135211411.03998,1426505.5,65499694573.720001,0.18923074704826018]
[null,3,"Public sector entities",7155101819.7799997,0,7155101819.7799997,0,0,0]
[null,4,"Multilateral development banks",8660851803.6800003,0,8660851803.6800003,0,0,0]
[null,5,"International organisations",0,0,0,0,0,0]
[null,6,"Institutions",22423764885.75,0,6270960978.2700005,0,644382496.37,0.10275657887250461]
[null,7,"Corporates",17185075594.75,0,498765120.26999998,0,249382560.13,0.49999999998997524]
[null,8,"Retail",0,0,0,0,0,0]
[null,9,"Secured by mortgages on immovable property",21872351.989999998,0,21872351.989999998,0,21872351.989999998,1]
[null,10,"Exposures in default",0,0,0,0,0,0]
[null,11,"Exposures associated with particularly high risk",0,0,0,0,0,0]
[null,12,"Covered bonds",29046379333.27,0,29046379333.27,0,2904637933.3299999,0.10000000000010328]
[null,13,"Institutions and corporates with a short-term credit assessment",0,0,0,0,0,0]
[null,14,"Collective investment undertakings",0,0,0,0,0,0]
[null,15,"Equity",0,0,0,0,0,0]
[null,16,"Other items",1678496069.6900001,0,1678496069.6900001,0,4157211338.8799996,2.4767477350410427]
[null,17,"TOTAL",441430600378.76001,2591659449,441664083647.72998,1426505.5,73477181254.420013,0.16636386488256255]

{"sheet":"EU CR5","index":33,"n_rows":24,"n_cols":19,"rows_kept":24,"cut":false,"hidden":false,"merged":[[4,2,6,2]]}
[]
[null,"Template EU CR5 – standardised approach"]
[null,"(amounts in NOK)"]
[]
[null,null," Exposure classes","Risk weight",null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Total"]
[null,null,null,0,0.02,0.04,0.1,0.2,0.35,0.5,0.7,0.75,1,1.5,2.5,3.7,12.5,"Others"]
[null,null,null,"a","b","c","d","e","f","g","h","i","j","k","l","m","n","o","p"]
[null,1,"Central governments or central banks",42196444759.75,0,0,0,0,0,0,0,0,0,0,0,0,0,0,42196444759.75]
[null,2,"Regional government or local authorities",19879266362.779999,0,0,0,325947096225.04999,0,0,0,0,310275328.70999998,0,0,0,0,0,346136637916.53998]
[null,3,"Public sector entities",7155101819.7799997,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7155101819.7799997]
[null,4,"Multilateral development banks",8660851803.6800003,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8660851803.6800003]
[null,5,"International organisations",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[null,6,"Institutions",6620618638.6999998,823641446.02999997,1180628334.3800001,0,4911913171.0900002,0,3495906539.0100002,0,0,0,0,0,0,0,0,17032708129.210001]
[null,7,"Corporates",0,0,0,0,0,0,498765120.26999998,0,0,0,0,0,0,0,0,498765120.26999998]
[null,8,"Retail",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[null,9,"Secured by mortgages on immovable property",0,0,0,0,0,0,0,0,0,21872351.989999998,0,0,0,0,0,21872351.989999998]
[null,10,"Exposures in default",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[null,11,"Exposures associated with particularly high risk",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[null,12,"Covered bonds",0,0,0,29046379333.27,0,0,0,0,0,0,0,0,0,0,0,29046379333.27]
[null,13,"Institutions and corporates with a short-term credit assessment",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[null,14,"Unit or shares in collective investment undertakings",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[null,15,"Equity",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]
[null,16,"Other items",0,0,0,0,0,0,0,0,0,26019223.559999999,0,1652476846.1300001,0,0,0,1678496069.6900001]
[null,17,"TOTAL",84512283384.690002,823641446.02999997,1180628334.3800001,29046379333.27,330859009396.15002,0,3994671659.2800002,0,0,358166904.25999999,0,1652476846.1300001,0,0,0,452427257304.19006]

{"sheet":"Table EU CCRA","index":34,"n_rows":8,"n_cols":4,"rows_kept":8,"cut":false,"hidden":false,"merged":[]}
[]
[null,"Table EU CCRA – Qualitative disclosure related to CCR"]
[null,null,null,"Flexible format disclosure"]
[null,"(a)","Article 439 (a) CRR\n\nDescription of the methodology used to assign internal capital and credit limits for counterparty credit exposures, including the methods to assign those limits to exposures to central counterparties","Counterparty credit exposures are constrained by a limit set for large exposures, in addition there are sub-limits for credit exposures towards issuers of securities and derivative counterparties. These sub-limits depend on rating, sector and duration. All counterparties are subject to an annual review and approval process."]
[null,"(b)","Article 439 (b) CRR\n\nDescription of policies related to guarantees and other credit risk mitigants, such as the policies for securing collateral and establishing credit reserves","KBN enters into derivative transactions in order to hedge interest rate and currency risk. Counterparties in derivative transactions are financial institutions or central counterparties. In addition to strict rating requirements, the risk inherent in derivative transactions is mitigated through the use of ISDA agreements (offsetting) with Credit Support Annex. Such agreements, that include the exchange of cash collateral, have been made with all derivative counterparties.\nReverse repo agreements include asset encumbrance with strict rating requirements."]
[null,"(c)","Article 439 (c) CRR\n\nDescription of policies with respect to Wrong-Way risk as defined in Article 291 of the CRR","KBN only receives cash as collateral for variation margin, thus no wrong way risk.\nIn reverse repo transactions, the counterparty’s own bonds are not accepted."]
[null,"(d)","Article 431 (3) and (4) CRR\n\nAny other risk management objectives and relevant policies related to CCR","N/A"]
[null,"(e)","Article 439 (d) CRR\n\nThe amount of collateral the institution would have to provide if its credit rating was downgraded","KBN would have to transfer additional collateral at a rating level of around BBB."]

{"sheet":"EU MRA","index":35,"n_rows":6,"n_cols":4,"rows_kept":6,"cut":false,"hidden":false,"merged":[[1,1,1,3]]}
[]
[null,"Table EU MRA: Qualitative disclosure requirements related to market risk"]
[null,null,null,"Flexible format disclosure"]
[null,"a","Points (a) and (d) of Article 435 (1) CRR\n\nA description of the institution's strategies and processes to manage market risk, including: \n- An explanation of management’s strategic objectives in undertaking trading activities, as well as the processes implemented to identify, measure, monitor and control the institution’s market risks \n- A description of their policies for hedging and mitigating risk and strategies and processes for monitoring the continuing effectiveness of hedges","KBNs business model consists only of banking business and KBN does not participate in any trading activities i.e. no market making, proprietary trading and/or customer trading. Market risk in KBN is purely a function of funding and lending activities as well as liquidity management. Inherent market risk before hedging stems from currency risk and interest rate risk from funding and lending and credit spread risk from lending and liquidity portfolio investments. All currency risk stems from funding in foreign currency which is entirely hedged. A residual risk from hedging of currency risk is cross currency basis swap spread risk and this is retained. Interest rate risk from funding and lending activities is hedged to short term rates i.e., 3 months or lower. Credit spread risk stems from fixed rate lending and investments, and this is retained. All market risks, both hedged, retained, and residual risks are constrained by risk limits and limit utilisation is calculated, controlled, and reported daily. \nKBN has implemented an annual process for risk identification and a process for new products that includes risk identification and assessment. \nMarket risk in KBN is governed by the risk appetite statement and the financial risk strategy which are both approved by the Board of Directors. The risk appetite statement contains risk appetite thresholds and risk limits. "]
[null,"b","Point (b) of Article 435 (1) CRR\n\nA description of the structure and organisation of the market risk management function, including a description of the market risk governance structure established to implement the strategies and processes of the institution discussed in row (a) above, and that describes the relationships and the communication mechanisms between the different parties involved in market risk management. \n","The CEO delegates limits for market risk to the Chief Capital Markets Officer who is responsible for funding and treasury in KBN. The capital markets department manages all market risk and is responsible for operationalising the financial risk strategy of KBN. The operationalisation of the financial risk strategy by the capital markets department is constrained by the risk appetite statement which contains an aggregated risk appetite threshold for market risk and specific risk limits for each market risk type.  The middle office within Capital Markets calculates the level of market risk and utilization of limits daily. The risk management function monitors limit utilisation daily and ensures escalation in case of breach of early warning, limit and threshold levels in accordance with internal guidelines. "]
[null,"c","Point (c ) of Article 435 (1) CRR\n\nScope and nature of risk reporting and measurement systems","KBNs trading and portfolio system contains all transaction contracts from assets, liabilities and derivatives. This represents a complete basis for all market risk in KBN. Daily risk and limit calculations are based on this system. Market risk sensitivities of these contracts are transferred from the portfolio system to a central data repository daily. Limit utilisation and market risk levels are calculated daily based on the holdings in the central data repository."]

{"sheet":"EU CCR1","index":36,"n_rows":17,"n_cols":11,"rows_kept":17,"cut":false,"hidden":false,"merged":[]}
[]
[null,"Template EU CCR1 – Analysis of CCR exposure by approach"]
[null,"(amounts in NOK)"]
[]
[null,null,null,"a","b","c","d","e","f","g","h"]
[null,null,null,"Replacement cost (RC)","Potential future exposure  (PFE)","EEPE","Alpha used for computing regulatory exposure value","Exposure value pre-CRM","Exposure value post-CRM","Exposure value","RWEA"]
[null,"EU1","EU - Original Exposure Method (for derivatives)",0,0,null,"1.4",0,0,0,0]
[null,"EU2","EU - Simplified SA-CCR (for derivatives)",0,0,null,"1.4",0,0,0,0]
[null,1,"SA-CCR (for derivatives)",1073019362.7599999,6571784260.4899998,null,"1.4",11800709017.52,10702725072.559999,10702725072.559999,2137846953.9799998]
[null,2,"IMM (for derivatives and SFTs)",null,null,0,0,0,0,0,0]
[null,"2a","Of which securities financing transactions netting sets",null,null,0,null,0,0,0,0]
[null,"2b","Of which derivatives and long settlement transactions netting sets",null,null,0,null,0,0,0,0]
[null,"2c","Of which from contractual cross-product netting sets",null,null,0,null,0,0,0,0]
[null,3,"Financial collateral simple method (for SFTs)",null,null,null,null,0,0,0,0]
[null,4,"Financial collateral comprehensive method (for SFTs)",null,null,null,null,23817.54,3630414.25,3630414.25,11804.42]
[null,5,"VaR for SFTs",null,null,null,null,0,0,0,0]
[null,6,"Total",null,null,null,null,11800732835.059999,10706355486.809999,10706355486.809999,2137858758.4000001]

{"sheet":"EU CCR2","index":37,"n_rows":12,"n_cols":5,"rows_kept":12,"cut":false,"hidden":false,"merged":[]}
[]
[null,"Template EEU CCR2 – Transactions subject to own funds requirements for CVA risk"]
[null,"(amounts in NOK)"]
[null,null,null,"a","b"]
[null,null,null,"Exposure value","RWEA"]
[]
[null,1,"Total transactions subject to the Advanced method",0,0]
[null,2,"   (i) VaR component (including the 3× multiplier)",0,0]
[null,3,"   (ii) stressed VaR component (including the 3× multiplier)",0,0]
[null,4,"Transactions subject to the Standardised method",8167661001.9899998,0]
[null,"EU4","Transactions subject to the Alternative approach (Based on the Original Exposure Method)",0,0]
[null,5,"Total transactions subject to own funds requirements for CVA risk ",8167661001.9899998,2530177493.5700002]

{"sheet":"EU CCR3","index":38,"n_rows":18,"n_cols":15,"rows_kept":18,"cut":false,"hidden":false,"merged":[]}
[]
[null,"Template EU CCR3 – Standardised approach – CCR exposures by regulatory exposure class and risk weights"]
[null,"(amounts in NOK)"]
[]
[]
[null,null,"Exposure classes","a","b","c","d","e","f","g","h","i","j","k"," l"]
[null,null,null,0,0.02,0.04,0.1,0.2,0.5,0.7,0.75,1,1.5,"Others","Total exposure value "]
[null,1,"Central governments or central banks ",42196444759.75,0,0,0,0,0,0,0,0,0,0,42196444759.75]
[null,2,"Regional government or local authorities ",19879266362.779999,0,0,0,325947096225.04999,0,0,0,310275328.70999998,0,0,346136637916.53998]
[null,3,"Public sector entities",7155101819.7799997,0,0,0,0,0,0,0,0,0,0,7155101819.7799997]
[null,4,"Multilateral development banks",8660851803.6800003,0,0,0,0,0,0,0,0,0,0,8660851803.6800003]
[null,5,"International organisations",0,0,0,0,0,0,0,0,0,0,0,0]
[null,6,"Institutions",6620618638.6999998,823641446.02999997,1180628334.3800001,0,4911913171.0900002,3495906539.0100002,0,0,0,0,0,17032708129.210001]
[null,7,"Corporates",0,0,0,0,0,498765120.26999998,0,0,0,0,0,498765120.26999998]
[null,8,"Retail",0,0,0,0,0,0,0,0,0,0,0,0]
[null,9,"Institutions and corporates with a short-term credit assessment",0,0,0,0,0,0,0,0,0,0,0,0]
[null,10,"Other items",0,0,0,0,0,0,0,0,0,0,0,0]
[null,11,"Total exposure value",84512283384.689987,823641446.02999997,1180628334.3800001,0,330859009396.14001,3994671659.2800002,0,0,310275328.70999998,0,0,421680509549.23004]

{"sheet":"EU CRR5","index":39,"n_rows":18,"n_cols":11,"rows_kept":18,"cut":false,"hidden":false,"merged":[]}
[]
[null,"Template EU CCR5 – Composition of collateral for CCR exposures"]
[null,"Fixed format"]
[null,"(amounts in NOK)"]
[]
[null,null,null,"a","b","c","d","e","f","g","h"]
[null,null,null,"Collateral used in derivative transactions",null,null,null,"Collateral used in SFTs"]
[null,null,"Collateral type","Fair value of collateral received",null,"Fair value of posted collateral",null,"Fair value of collateral received",null,"Fair value of posted collateral"]
[null,null,null,"Segregated","Unsegregated","Segregated","Unsegregated","Segregated","Unsegregated","Segregated","Unsegregated"]
[null,1,"Cash – domestic currency",0,4403605225.5,0,0,0,0,0,0]
[null,2,"Cash – other currencies",0,2168080532.23,2418718973.8499999,27087746160.630001,0,0,0,0]
[null,3,"Domestic sovereign debt",0,0,0,0,0,0,0,0]
[null,4,"Other sovereign debt",0,0,0,0,0,0,0,0]
[null,5,"Government agency debt",0,0,0,0,0,0,0,0]
[null,6,"Corporate bonds",0,0,0,0,0,0,0,0]
[null,7,"Equity securities",0,0,0,0,0,0,0,0]
[null,8,"Other collateral",0,0,0,0,0,0,0,3630843905.6500001]
[null,9,"Total",0,6571685757.7299995,2418718973.8499999,27087746160.630001,0,0,0,3630843905.6500001]

{"sheet":"EU CRR8","index":40,"n_rows":27,"n_cols":5,"rows_kept":27,"cut":false,"hidden":false,"merged":[]}
[]
[null,"Template EU CCR8 – Exposures to CCPs"]
[null,"Fixed format"]
[null,"(amounts in NOK)"]
[]
[null,null,null,"a","b"]
[null,null,null,"Exposure value ","RWEA"]
[null,1,"Exposures to QCCPs (total)",null,63697962.299999997]
[null,2,"Exposures for trades at QCCPs (excluding initial margin and default fund contributions); of which",2004269780.4200001,63697962.299999997]
[null,3,"   (i) OTC derivatives",0,0]
[null,4,"   (ii) Exchange-traded derivatives",0,0]
[null,5,"   (iii) SFTs",0,0]
[null,6,"   (iv) Netting sets where cross-product netting has been approved",2004269780.4200001,63697962.299999997]
[null,7,"Segregated initial margin",2418718973.8499999]
[null,8,"Non-segregated initial margin",0,0]
[null,9,"Prefunded default fund contributions",0,0]
[null,10,"Unfunded default fund contributions",0,0]
[null,11,"Exposures to non-QCCPs (total)",null,0]
[null,12,"Exposures for trades at non-QCCPs (excluding initial margin and default fund contributions); of which",0,0]
[null,13,"   (i) OTC derivatives",0,0]
[null,14,"   (ii) Exchange-traded derivatives",0,0]
[null,15,"   (iii) SFTs",0,0]
[null,16,"   (iv) Netting sets where cross-product netting has been approved",0,0]
[null,17,"Segregated initial margin",0]
[null,18,"Non-segregated initial margin",0,0]
[null,19,"Prefunded default fund contributions",0,0]
[null,20,"Unfunded default fund contributions",0,0]

{"sheet":"Table EU ORA","index":41,"n_rows":10,"n_cols":5,"rows_kept":10,"cut":false,"hidden":false,"merged":[]}
[]
[null,"Table EU ORA - Qualitative information on operational risk"]
[null,"Free format text boxes for disclosure of qualitative information"]
[]
[]
[null,"Legal basis","Row number","Qualitative information - Free format","Qualitative information - Free format"]
[null,"Points (a), (b), (c) and(d) of Article 435(1) CRR","(a)","Disclosure of the risk management objectives and policies","KBN’s objective is to avoid operational risk that can result in large losses or material disruptions.\n\nKBN has a limited risk appetite (low) for operational risks in aggregate. KBN has defined a selected number of operational risk sub-categories with specific statements on risk appetite:\n\n\tKBN has a low risk appetite for cyber risk, or the risk of experiencing large losses or disruptions due to a severe and successful cyber-attack.\n\tKBN has a very low risk appetite for compliance risk, or the risk of  non-compliance with external or internal rules.\n\tKBN has a low risk appetite for contributing to or being used for money laundering or terror financing.\n\nKBN applies a uniform and systematic approach to identifying operational risk. Regular risk assessments are conducted in close co-operation with all functions. These assessments contribute to prioritisation of KBN’s resources for risk-reduction activities. Operational risk is subject to continuous monitoring and reporting."]
[null,"Article 446 CRR","(b)","Disclosure of the approaches for the assessment of minimum own funds requirements","KBN applies the Basic Indicator Approach method to calculate own funds requirements for operational risk under Pillar 1. KBNs Principles for operational risk are used to assess the additional own funds requirements for operational risk under Pillar 2. This assessment is based partly on historical operational losses reported during the last 5-10 years, and partly based on a forward-looking assessment of operational risk.\n\nKBNs Principles for operational risk are based on the Basel definition of operational risk, which focus on people, process, system, and external events."]
[null,"Article 446 CRR","(c) ","Description of the AMA methodology approach used (if applicable)","N/A"]
[null,"Article 454 CRRR","(d)","Disclose the use of insurance for risk mitigation in the Advanced Measurement Approach (if applicable)","N/A"]

{"sheet":"Template EU OR1","index":42,"n_rows":13,"n_cols":11,"rows_kept":13,"cut":false,"hidden":false,"merged":[[5,1,7,2],[6,3,6,5],[6,9,7,9],[6,10,7,10]]}
[]
[null," Template EU OR1 - Operational risk own funds requirements and risk-weighted exposure amounts"]
[null,"(amounts in NOK)"]
[]
[]
[null,"Banking activities",null,"a","b","c","040","050",null,"d","e"]
[null,null,null,"Relevant indicator",null,null,"Own funds","Total operational risk-weighted exposure amount",null,"Own funds requirements","Risk exposure amount"]
[null,null,null,"Year-3","Year-2","Last year","requirement"]
[null,1,"Banking activities subject to basic indicator approach (BIA)",1805505594,1874836286,117985395,189916364,2373954547.1129999]
[null,2,"Banking activities subject to standardised (TSA) / alternative standardised (ASA) approaches"]
[null,3,"Subject to TSA:"]
[null,4,"Subject to ASA:"]
[null,5,"Banking activities subject to advanced measurement approaches AMA"]

{"sheet":"REMA","index":43,"n_rows":33,"n_cols":20,"rows_kept":33,"cut":false,"hidden":false,"merged":[[4,19,32,19],[5,1,9,1],[5,2,5,18],[6,3,6,18],[7,3,7,18],[8,3,8,18],[9,3,9,18],[10,1,15,1],[10,2,10,18],[11,3,11,18],[12,3,12,18],[13,3,13,18],[14,3,14,18],[15,3,15,18],[27,1,28,1],[27,2,27,18],[28,3,28,18],[16,2,16,18],[17,2,17,18],[18,1,22,1],[18,2,18,18],[19,3,19,18],[20,3,20,18],[21,3,21,18],[22,3,22,18],[23,1,26,1],[23,2,23,18],[24,3,24,18],[25,3,25,18],[26,3,26,18],[29,2,29,18],[30,1,31,1],[30,2,30,18],[31,3,31,18],[32,2,32,18]]}
[]
[null,"Table EU  REMA - Remuneration policy"]
[]
[null,"Institutions shall describe the main elements of their remuneration policies and how they implement these policies. In particular, the following elements, where relevant, shall be described:"]
[null,"Qualitative disclosures",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"The Board’s statement on the determination of salaries and other remuneration to senior executives\nThe Board of Directors will submit the following statement on the salary and other remuneration of senior executives to the Annual General Meeting in 2023.1\nTHE REMUNERATION SCHEME FOR SENIOR EXECUTIVES\nKBN’s remuneration policy for senior executives is anchored in the companies value proposition and its personnel policy, and is in line with its owners expectations of the company and its guidelines for the remuneration of senior executives. The central principles observed when determining the salaries of senior executives, are that overall remuneration should be competitive but not market-leading when compared with equivalent companies in the banking and finance sector.\nKBNs remuneration scheme for senior executives, complies with the provisions of the Financial Undertakings Act2, with regulation3, the circular on this regulation issued by the Financial Supervisory Authority of Norway4, the Norwegian Governments Guidelines for remuneration of senior executives5, and the Public Limited Liability Companies Act6 , with regulations7, on salaries and remuneration to senior executives.\nRemuneration for all employees, including senior executives, consists of a fixed salary, variable salary payments, pensions and other benefits, including personnel insurance, newspapers  and mobile telephone. KBN does not operate a share-based remuneration program or option. Fixed salary is the main element of remuneration received. Each year the Board of Directors sets quantitative criteria for variable salary payments for the next financial year, and can award payments in the following financial year of up to 1.5 times one months salary for all employees. \nAll employees’ fixed salaries are adjusted each year with effect from 1 January based on a combined assessment of KBNs results, their contribution to the attainment of shared targets and their adherence to the banks values, with leadership skills also forming part of the assessment for managers with reporting staff.\nSenior executives are defined as the Chief Executive Officer (the \"CEO\") and members of the CEOs management team, as shown in the table below. \nMANAGEMENT SYSTEM AND DECISION-MAKING PROCESS\nThe Board of Directors has appointed an advisory committee - the Remuneration Committee - which carries out preparatory work on the principles applicable to remuneration, guidelines for variable salary, and guidelines for the remuneration of senior executives. The Board has issued a mandate for the work of the Remuneration Committee. \nMinutes of the meetings of the Remuneration Committee are circulated to the Board. The Remuneration Committee has three members, who are appointed annually by and among the members of the Board. At year end 2022, the Committee’s members are Brit Rugland (Chair), Petter Steen jr. and Harald Jacobsen (employee representative). \nEach year the Board approves guidelines for variable salary payments. Guidelines for remuneration to senior executives are adopted by the Board and submitted to the Annual General Meeting for approval in the event of change, or minimum every four years. KBN carries out an annual review of the practical implementation of the variable element of remuneration in the form of a written report, that is reviewed by the internal auditor in accordance with the Financial Undertakings Regulation. \nThe Board determines the remuneration of the CEO. The CEO determines the remuneration of the other senior executives within the limits set by the Boards guidelines, and takes into account the Boards views when making final decisions on such remuneration. The CEOs decisions on the remuneration of senior executives are subsequently submitted to the Board for information. \nREMUNERATION OF KBNs SENIOR EXECUTIVES IN 2022\nFixed salary \nFixed salary payable in 2022 included the normal annual salary increase.\nVariable salary\nIn line with the guidelines for variable salary and achieved results in 2022, no variable salary was earned in 2022. Correspondingly, in 2021 all employees were granted a variable salary corresponding to 0.88 monthly salaries, paid out in 2022.\nOther benefits\nOther benefits include insurance arrangements, mobile phone, internet, newspaper subscription etc. on the same terms and conditions as apply to other employees. \nThe insurance arrangements relate to various forms of personnel insurance including health insurance and travel insurance, as well as disability insurance and life insurance up to the current level of fixed salary.  \nThe Chief Lending Officer is entitled to a fixed annual car benefit of NOK 50,000. \nThe CEO has a contractual entitlement, subject to certain conditions, to severance pay equivalent to one year's fixed salary.\nPension benefits\nKBNs pension scheme has since 2018 been a defined contribution scheme for salaries under 12x Base amount (G) administered by Storebrand Livsforsikring AS.  The defined contribution pension scheme has a deposit rate of 7% for salaries between zero and 7.1G and 18% for salaries between 7.1 and 12G. A contractual pension plan (AFP) in the private sector associated with the joint scheme, is entered into as part of the collective agreement. Related insurance coverings are included in the scheme and include disability pension scheme with child allowance without the right to paid-up policies, child pension and group life insurance / life level term insurance. The defined contribution scheme applies to all employees, except for those who were 55 years or older as of 1 January 2018 and employees who were partially or fully disabled with the right to sickness benefits as of 1 January 2018. These are covered by the previous scheme administered by KLP, which entitles its members to a life expectancy adjusted retirement pension upon the completion of 30 years of service equivalent to 66% of base salary at the time of leaving KBN. This scheme also includes disability and survivors pensions, as well as contractual early retirement. "]
[null,"(a)","Information relating to the bodies that oversee remuneration. Disclosures shall include:"]
[null,null,"•","Name, composition and mandate of the main body (management body or remuneration committee as applicable) overseeing the remuneration policy and the number of meetings held by that main body during the financial year."]
[null,null,"•","External consultants whose advice has been sought, the body by which they were commissioned, and in which areas of the remuneration framework."]
[null,null,"•","A description of the scope of the institution’s remuneration policy (eg by regions, business lines), including the extent to which it is applicable to subsidiaries and branches located in third countries."]
[null,null,"•","A description of the staff or categories of staff whose professional activities have a material impact on institutions' risk profile."]
[null,"(b)","Information relating to the design and structure of the remuneration system for identified staff. Disclosures shall include:"]
[null,null,"•","An overview of the key features and objectives of remuneration policy, and information about the decision-making process used for determining the remuneration policy and the role of the relevant stakeholders."]
[null,null,"•","Information on the criteria used for performance measurement and ex ante and ex post risk adjustment."]
[null,null,"•","Whether the management body or the remuneration committee where established reviewed the institution’s remuneration policy during the past year, and if so, an overview of any changes that were made, the reasons for those changes and their impact on remuneration."]
[null,null,"•","Information of how the institution ensures that staff in internal control functions are remunerated independently of the businesses they oversee."]
[null,null,"•","Policies and criteria applied for the award of guaranteed variable remuneration and severance payments."]
[null,"(c)","Description of the ways in which current and future risks are taken into account in the remuneration processes. Disclosures shall include an overview of the key risks, their measurement and how these measures affect remuneration."]
[null,"(d)","The ratios between fixed and variable remuneration set in accordance with point (g) of Article 94(1) CRD."]
[null,"(e)","Description of the ways in which the institution seeks to link performance during a performance measurement period with levels of remuneration. Disclosures shall include:"]
[null,null,"•","An overview of main performance criteria and metrics for institution, business lines and individuals."]
[null,null,"•","An overview of how amounts of individual variable remuneration are linked to institution-wide and individual performance."]
[null,null,"•","Information on the criteria used to determine the balance between different types of instruments awarded including shares, equivalent ownership interest, options and other instruments."]
[null,null,"•","Information of the measures the institution will implement to adjust variable remuneration in the event that performance metrics are weak, including the institution’s criteria for determining “weak” performance metrics."]
[null,"(f)","Description of the ways in which the institution seeks to adjust remuneration to take account of longterm performance. Disclosures shall include:"]
[null,null,"•","An overview of the institution’s policy on deferral, payout in instrument, retention periods and vesting of variable remuneration including where it is different among staff or categories of staff."]
[null,null,"•","Information of the institution’ criteria for ex post adjustments (malus during deferral and clawback after vesting, if permitted by national law)."]
[null,null,"•","Where applicable, shareholding requirements that may be imposed on identified staff."]
[null,"(g)","The description of the main parameters and rationale for any variable components scheme and any other non-cash benefit in accordance with point (f) of Article 450(1) CRR. Disclosures shall include:"]
[null,null,"•","Information on the specific performance indicators used to determine the variable components of remuneration and the criteria used to determine the balance between different types of instruments awarded, including shares, equivalent ownership interests, share-linked instruments, equivalent non cash-instruments, options and other instruments."]
[null,"(h)","Upon demand from the relevant Member State or competent authority, the total remuneration for each member of the management body or senior management."]
[null,"(i)","Information on whether the institution benefits from a derogation laid down in Article 94(3) CRD in accordance with point (k) of Article 450(1) CRR."]
[null,null,"•","For the purposes of this point, institutions that benefit from such a derogation shall indicate whether this is on the basis of point (a) and/or point (b) of Article 94(3) CRD. They shall also indicate for which of the remuneration principles they apply the derogation(s), the number of staff members that benefit from the derogation(s) and their total remuneration, split into fixed and variable remuneration."]
[null,"(j)","Large institutions shall disclose the quantitative information on the remuneration of their collective management body, differentiating between executive and non-executive members in accordance with Article 450(2) CRR."]

{"sheet":"REM1","index":44,"n_rows":28,"n_cols":9,"rows_kept":28,"cut":false,"hidden":false,"merged":[[4,2,4,4],[5,2,14,3],[15,2,26,3]]}
[]
[null,null,"Template EU REM1 - Remuneration awarded for the financial year "]
[null,null,"(amounts in NOK)"]
[null,null,null,null,null,"a","b","c","d"]
[null,null,null,null,null,"MB Supervisory function","MB Management function ","Other senior management","Other identified staff"]
[null,1,"Fixed remuneration",null,"Number of identified staff",7000,"N/A",8000,1000]
[null,2,null,null,"Total fixed remuneration",1916000,null,16188000,2073000]
[null,3,null,null,"Of which: cash-based",1916000,null,16188000,2073000]
[null,4,null,null,"(Not applicable in the EU)",0,null,0,0]
[null,"EU-4a",null,null,"Of which: shares or equivalent ownership interests",0,null,0,0]
[null,5,null,null,"Of which: share-linked instruments or equivalent non-cash instruments ",0,null,0,0]
[null,"EU-5x",null,null,"Of which: other instruments",0,null,0,0]
[null,6,null,null,"(Not applicable in the EU)",0,null,0,0]
[null,7,null,null,"Of which: other forms",0,null,0,0]
[null,8,null,null,"(Not applicable in the EU)",0,null,0,0]
[null,9,"Variable remuneration",null,"Number of identified staff",0,null,8000,1000]
[null,10,null,null,"Total variable remuneration",0,null,1011000,149000]
[null,11,null,null,"Of which: cash-based",0,null,1011000,149000]
[null,12,null,null,"Of which: deferred",0,null,111000,19000]
[null,"EU-13a",null,null,"Of which: shares or equivalent ownership interests",0,null,0,0]
[null,"EU-14a",null,null,"Of which: deferred",0,null,0,0]
[null,"EU-13b",null,null,"Of which: share-linked instruments or equivalent non-cash instruments ",0,null,0,0]
[null,"EU-14b",null,null,"Of which: deferred",0,null,0,0]
[null,"EU-14x",null,null,"Of which: other instruments",0,null,0,0]
[null,"EU-14y",null,null,"Of which: deferred",0,null,0,0]
[null,15,null,null,"Of which: other forms",0,null,0,0]
[null,16,null,null,"Of which: deferred",0,null,0,0]
[null,17,"Total remuneration (2 + 10)",null,null,1916000,null,17199000,2222000]

{"sheet":"REM3","index":45,"n_rows":31,"n_cols":11,"rows_kept":31,"cut":false,"hidden":false,"merged":[]}
[]
[null,"Template EU REM3 - Deferred remuneration "]
[null,"(amounts in NOK)"]
[]
[null,null,null,"a","b","c","d","e","f","EU - g","EU - h"]
[null,null,"Deferred and retained remuneration","Total amount of  deferred remuneration awarded for previous performance periods","\nOf which due to vest in the financial year","\nOf which vesting in subsequent financial years","Amount of performance adjustment made in the financial year to deferred remuneration  that was due to vest in the financial year","Amount of performance adjustment made in the financial year to deferred remuneration that was due to vest in future performance years","Total amount of adjustment during the financial year due to ex post implicit adjustments (i.e.changes of value of deferred remuneration due to the changes of prices of instruments)","Total amount of deferred remuneration awarded before the financial year actually paid out in the financial year ","Total of amount of  deferred remuneration awarded for previous performance period that has vested but is subject to retention periods"]
[null,1,"MB Supervisory function",0,0,0,0,0,0,0,0]
[null,2,"Cash-based"]
[null,3,"\nShares or equivalent ownership interests"]
[null,4,"Share-linked instruments or equivalent non-cash instruments "]
[null,5,"Other instruments"]
[null,6,"Other forms"]
[null,7,"MB Management function",0,0,0,0,0,0,0,0]
[null,8,"Cash-based"]
[null,9,"\nShares or equivalent ownership interests"]
[null,10,"Share-linked instruments or equivalent non-cash instruments "]
[null,11,"Other instruments"]
[null,12,"Other forms"]
[null,13,"Other senior management",1011000,899000,111000,0,0,0,0,0]
[null,14,"Cash-based",1011000,899000,111000]
[null,15,"\nShares or equivalent ownership interests"]
[null,16,"Share-linked instruments or equivalent non-cash instruments "]
[null,17,"Other instruments"]
[null,18,"Other forms"]
[null,19,"Other identified staff",149000,131000,19000]
[null,20,"Cash-based"]
[null,21,"\nShares or equivalent ownership interests"]
[null,22,"Share-linked instruments or equivalent non-cash instruments "]
[null,23,"Other instruments"]
[null,24,"Other forms"]
[null,25,"Total amount"]

{"sheet":"REM4","index":46,"n_rows":17,"n_cols":4,"rows_kept":17,"cut":false,"hidden":false,"merged":[]}
[]
[null,"Template EU REM4 - Remuneration of 1 million EUR or more per year"]
[]
[null,null,null,"a"]
[null,null,"EUR","Identified staff that are high earners as set out in Article 450(i) CRR"]
[null,1,"1 000 000 to below 1 500 000",0]
[null,2,"1 500 000 to below 2 000 000",0]
[null,3,"2 000 000 to below 2 500 000",0]
[null,4,"2 500 000 to below 3 000 000",0]
[null,5,"3 000 000 to below 3 500 000",0]
[null,6,"3 500 000 to below 4 000 000",0]
[null,7,"4 000 000 to below 4 500 000",0]
[null,8,"4 500 000 to below 5 000 000",0]
[null,9,"5 000 000 to below 6 000 000",0]
[null,10,"6 000 000 to below 7 000 000",0]
[null,11,"7 000 000 to below 8 000 000",0]
[null,"x","To be extended as appropriate, if further payment bands are needed.",0]

{"sheet":"REM5","index":47,"n_rows":13,"n_cols":12,"rows_kept":13,"cut":false,"hidden":false,"merged":[[4,2,4,4],[4,5,4,11]]}
[]
[null,"Template EU REM5 - Information on remuneration of staff whose professional activities have a material impact on institutions’ risk profile (identified staff)"]
[null,"(amounts in 1000 NOK)"]
[null,null,"a ","b","c","d","e","f","g","h","i","j"]
[null,null,"Management body remuneration",null,null,"Business areas"]
[null,null,"MB Supervisory function","MB Management function","Total MB","Investment banking","Retail banking","Asset management","Corporate functions","Independent internal control functions","All other","Total "]
[null,"Total number of identified staff"]
[null,"Of which: members of the MB",7,null,7]
[null,"Of which: other senior management",null,null,null,1,1,null,3,2]
[null,"Of which: other identified staff",null,null,null,1]
[null,"Total remuneration of identified staff",2313,null,2313,4683,1957,null,8943,3838]
[null,"Of which: variable remuneration ",null,null,null,311,128,null,535,186]
[null,"Of which: fixed remuneration ",2313,null,2313,4372,1829,null,8408,3652]

{"sheet":"Template EU AE1","index":48,"n_rows":16,"n_cols":11,"rows_kept":16,"cut":false,"hidden":false,"merged":[]}
[]
[null,"Template EU AE1 - Encumbered and unencumbered assets"]
[null,"(amounts in NOK)"]
[]
[null,null,null,"Carrying amount of encumbered assets",null,"Fair value of encumbered assets",null,"Carrying amount of unencumbered assets",null,"Fair value of unencumbered assets"]
[null,null,null,null,"of which notionally eligible EHQLA and HQLA",null,"of which notionally eligible EHQLA and HQLA",null,"of which EHQLA and HQLA",null,"of which EHQLA and HQLA"]
[null,null,null,"010","030","040","050","060","080","090","100"]
[null,"010","Assets of the disclosing institution",46407897751.278236,3067440000,null,null,439476128178.15186,439752104309.06665]
[null,"030","Equity instruments"]
[null,"040","Debt securities",3067440000,3067440000,null,3067440000,115197842315.48563,115197842315.48563,null,115197842315.48563]
[null,"050","of which: covered bonds",400000000,null,null,null,29046379333.272621,29046379333.272621,null,29046379333.272621]
[null,"060","of which: securitisations",null,null,null,null,0]
[null,"070","of which: issued by general governments",1567440000,1567440000,null,1567440000,63799266529.199677,63799266529.199677,null,63799266529.199677]
[null,"080","of which: issued by financial corporations",1100000000,1100000000,null,1100000000,6037477709.2923574,6037477709.2923574,null,6037477709.2923574]
[null,"090","of which: issued by non-financial corporations",null,null,null,null,7155101819.7776861,7155101819.7776861,null,7155101819.7776861]
[null,"120","Other assets",43340457751.278236,null,null,null,-275976130.91473389]

{"sheet":"Template EU AE2","index":49,"n_rows":22,"n_cols":7,"rows_kept":22,"cut":false,"hidden":false,"merged":[]}
[]
[null,"Template EU AE2 - Collateral received and own debt securities issued"]
[null,"(amounts in NOK)"]
[]
[null,null,null,"Fair value of encumbered collateral received or own debt securities issued",null,"Unencumbered"]
[null,null,null,null,null,"Fair value of collateral received or own debt securities issued available for encumbrance"]
[null,null,null,null,"of which notionally eligible EHQLA and HQLA",null,"of which EHQLA and HQLA"]
[null,null,null,"010","030","040","060"]
[null,"130","Collateral received by the disclosing institution",null,null,7454536762.897378]
[null,"140","Loans on demand"]
[null,"150","Equity instruments"]
[null,"160","Debt securities"]
[null,"170","of which: covered bonds"]
[null,"180","of which: securitisations"]
[null,"190","of which: issued by general governments"]
[null,"200","of which: issued by financial corporations"]
[null,"210","of which: issued by non-financial corporations"]
[null,"220","Loans and advances other than loans on demand"]
[null,"230","Other collateral received",null,null,7454536762.897378]
[null,"240","Own debt securities issued other than own covered bonds or securitisations"]
[null,241," Own covered bonds and securitisations issued and not yet pledged"]
[null,250,"TOTAL COLLATERAL RECEIVED AND OWN DEBT SECURITIES ISSUED ",46407897751.278236]

{"sheet":"Template EU AE3","index":50,"n_rows":6,"n_cols":5,"rows_kept":6,"cut":false,"hidden":false,"merged":[]}
[]
[null,"Template EU AE3 - Sources of encumbrance"]
[null,"(amounts in NOK)"]
[null,null,null,"Matching liabilities, contingent liabilities or securities lent","Assets, collateral received and own\ndebt securities issued other than covered bonds and securitisations encumbered"]
[null,null,null,"010","030"]
[null,"010","Carrying amount of selected financial liabilities",39070097208.999992,43340457751.278236]

{"sheet":"Table EU AE4","index":51,"n_rows":8,"n_cols":4,"rows_kept":8,"cut":false,"hidden":false,"merged":[]}
[]
[null,"Table EU AE4 - Accompanying narrative information"]
[null,"Free format text boxes for disclosure of qualitative information, in accordance with Article 443 CRR"]
[]
[]
[null,"Row number","Qualitative information - Free format","Qualitative information - Free format"]
[null,"(a)","General narrative information on asset encumbrance","KBN’s asset encumbrance includes posted collateral (cash) on derivative contracts, initial margin to London Clearing House (bonds) and bonds in repo agreements."]
[null,"(b)","Narrative information on the impact of the business model on assets encumbrance and the importance of encumbrance to the institution's business model, which  provides users with the context of the disclosures required in Template EU AE1 and EU AE2.","The scope of asset encumbrance asset reduces KBN’s general economic leeway."]

{"sheet":"Table EU IRRBBA","index":52,"n_rows":15,"n_cols":4,"rows_kept":15,"cut":false,"hidden":false,"merged":[]}
[]
[null,"Table EU IRRBBA - Qualitative information on interest rate risks of non-trading book activities "]
[null,"Free format text boxes for disclosure of qualitative information"]
[]
[null,"Row number","Qualitative information - Free format","Qualitative information - Free format"]
[null,"(a)","A description of how the institution defines IRRBB for purposes of risk control and measurement.","IRRBB is defined as all fixed income risk factors, interest rate-, basis- and credit spread risk factors, of all exposures, on and off balance sheet, irrespective of accounting practice, for both net present value risk (EVE) and net interest income risk (NII) and aggregated net present value- and net interest income risk."]
[null,"(b)","A description of the institution's overall IRRBB management and mitigation strategies.","Interest rate risk strategy: hedge all interest rate risk from both assets and liabilities to short term rate (3 months or less). Limits set on overall, per currency and tenor for net present value- and net interest income sensitivity.\nCredit spread risk strategy: Stems from liquidity portfolio and fixed rate loans. No hedging of credit spread risk. Limits set on overall net present value- and net interest income sensitivity.\nCross currency basis risk: Stems from financial derivatives used in the hedging of currency risk. Limits set on overall, per currency and tenor for net present value sensitivity. Limits set on overall net interest income sensitivity."]
[null,"(c)","The periodicity of the calculation of the institution's IRRBB measures, and a description of the specific measures that the institution uses to gauge its sensitivity to IRRBB.","Daily for all exposures and risk measures. \nDescription of sensitivity measures for IRRBB: \n-\tNet present value sensitivity: Delta sensitivity of all tenors of all curves used for valuation, measured by one basis point shift in risk factor\n-\tIncome sensitivity: Change in income of all fixed income instruments over 9 risk horizons measured by one basis point shift in all cash flow risk factors."]
[null,"(d)","A description of the interest rate shock and stress scenarios that the institution uses to estimate changes in the economic value and in net interest income (if applicable).","For net present value risk KBN utilises the 6 supervisory outlier test scenarios.\nFor net interest income risk KBN utilises the 6 supervisory outlier test scenarios. For internal risk management purposes expected interest income for the next year is deducted from the outcome as this is expected to accrue."]
[null,"(e )","A description of the key modelling and parametric assumptions different from those used for disclosure of template EU IRRBB1 (if applicable).","N/A"]
[null,"(f)","A high-level description of how the bank hedges its IRRBB, as well as the associated\naccounting treatment (if applicable).","For description of hedging of interest rate risk see 15.1 b). All hedging instruments are measured at fair value. All lending except fixed rate loans is measured at amortised cost. Fixed rate loans issued before 2022 are measured at fair value. Fixed rate loans starting after 1. January 2022 that are hedged with at swap and that fulfil the criteria for hedge accounting and is designated as such, are accounted for as fair value hedges. Floating rate bonds in the liquidity portfolio without hedges are measured at amortised cost while bond holdings with hedges are measured at fair value. Issued bonds without hedges are measured at amortised cost, while (most) funding issuances hedged with interest rate swaps are accounted for as fair value hedge, while all other funding contracts are measured at fair value."]
[null,"(g)","A description of key modelling and parametric assumptions used for the IRRBB measures in template EU IRRBB1 (if applicable).","N/A (as specified in section 4.5 in EBA/GL/208/02) "]
[null,"(h)","Explanation of the significance of the IRRBB measures and of their significant variations since previous disclosures","Interest floors are less effective or no longer effective due to the rise in interest rate levels. This has increased the potential loss under certain scenarios. This is considered as a positive effect since net interest income for KBN and banks in general increase with higher interest rate levels."]
[null,"(i)","Any other relevant information regarding the IRRBB measures disclosed in template EU IRRBB1 (optional)","N/A"]
[null,"(1) (2)","Disclosure of the average and longest repricing maturity assigned to non-maturity deposits","N/A as KBN is not allowed to receive deposits."]

{"sheet":"EU IRRBB1","index":53,"n_rows":14,"n_cols":7,"rows_kept":14,"cut":false,"hidden":false,"merged":[[6,3,6,4],[6,5,6,6]]}
[]
[null," Template EU IRRBB1 - Interest rate risks of non-trading book activities"]
[null,"(amounts in NOK)"]
[]
[]
[null,"Supervisory shock scenarios",null,"a","b","c","d"]
[null,null,null,"Changes of the economic value of equity",null,"Changes of the net interest income"]
[null,null,null,"Current period","Last period","Current period","Last period"]
[null,1,"Parallel up",-183000000,null,182000000]
[null,2,"Parallel down ",16000000,null,-131000000]
[null,3,"Steepener ",-168000000,null,0]
[null,4,"Flattener",-2000000,null,0]
[null,5,"Short rates up",-66000000,null,0]
[null,6,"Short rates down",-75000000,null,0]